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Summary 
The immune system has to fulfill the remarkable task of defending the organism against a 
plethora of pathogens, while at the same time remaining tolerant to self. T cells are the main 
mediators of adaptive immune responses, as they are essential for both cellular and humoral 
immunity. During their development in the thymus T cells pass through tightly controlled 
check points, namely positive and negative selection, that ensure that only T cells expressing 
antigen receptors that are self Major Histocompatibility Complex (MHC) restricted and self 
tolerant are generated. Recognition of MHC/peptide ligands (MHCp) on cortical thymic 
epithelial cells (cTEC) and medullary thymic epithelial cells (mTEC) serves non-redundant 
functions in positive and negative selection of T cells, respectively. However, the antigen 
sampling and processing pathways that shuttle peptides to the MHC class II loading 
compartment (MIIC) in thymic epithelial cells (TEC) remain elusive. Although it is generally 
accepted that MHCII/peptide epitopes (MHCII/p) are generated through lysosomal 
processing of endocytosed polypeptides about 20% of peptides bound by MHC class II 
molecules of hematopoietic antigen presenting cells (APC) originate from intracellular 
proteins. TEC, unlike hematopoietic APC, are inefficient in capturing and/or presenting 
extracellular antigens, implying that TEC might primarily concentrate on their intracellular 
milieu for the generation of MHCII/p repertoire. Several pathways have been implicated in 
non-classical, endogenous MHCII loading: chaperone mediated autophagy, macroautophagy 
and the transporter associated with antigen processing (TAP)-dependent pathway, but 
respective in vivo significance of these processes remained unknown.   
Here we addressed the role of macroautophagy (referred to as autophagy hereafter) in 
thymic epithelium in T cell development. Autophagy is an evolutionary conserved process 
responsible for the turnover of long lived cytoplasmic proteins and organelles. 
Autophagosomes fuse with late endosomes and lysosomes and thereby might deliver 
intracellular antigens to the MIIC compartment. 
We were able to show that TEC, unlike most other cells in the body, display a high 
constitutive autophagic activity. Genetic interference with autophagy specifically in thymic 
epithelium led to altered positive selection of certain MHC II- but not MHC I- restricted T cell 
specificities. Athymic nude mice grafted with an autophagy deficient thymus displayed severe 
colitis and immune mediated multi-organ tissue inflammation. On the basis of these findings 
we propose that autophagy shuttles intracellular antigens to MIIC in TEC and in that way 
contributes to the efficient positive selection and tolerance induction in developing CD4 T 
cells.  
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Zusammenfassung 
Aufgabe des Immunsystem ist es, den Organismus gegen eine Vielzahl von 
Krankheitserregern zu verteidigen und dabei die Toleranz gegenüber körpereigenen 
Strukturen aufrechtzuerhalten. T-Zellen sind eine der bedeutensten Komponenten der 
adaptiven Immunität, da sie sowohl für die humorale, als auch für die zelluläre Immunantwort 
essentiell sind. Während Ihrer Reifung im Thymus durchlaufen T-Zellen eine positive 
Selektion zur der Erkennung eigener MHC-Moleküle und eine negative Selektion, die 
sicherstellt, dass sich nur selbst-tolerante T-Zellen weiter entwickeln. Die Erkennung und 
Interaktion mit kortikalen und medullären Thymusepithelzellen (cTEC; mTEC)  ermöglicht 
diese wichtigen Selektionsprozesse. 
 Auswahl und Art der Prozessierung der für die Präsentation auf Thymusepitelzellen 
vorgesehenen Peptide sind noch weitgehend unbekannt. Obwohl MHC II – Moleküle 
vorwiegend in Lysosomen mit Peptiden endozytotisch aufgenommener Polypeptide beladen 
werden, sind etwa 20% aller MHC II gebundenen Peptide auf hämatopoetischen APCs 
intrazellulären Ursprungs. Im Gegensatz dazu endozytieren und präsentieren TEC 
extrazelluläre Antigene äußerst ineffizient. Dies deutet auf eine Spezialisierung von TEC auf 
die Präsentation intrazellulärer Antigene auf MHC II Molekülen hin. Es wurden bereits 
mehrer Möglichkeiten für die nicht-klassische, endogene Beladung von MHC II Molekülen 
beschrieben, unter anderem die Chaperon-vermittelte Autophagie, Macroautophagie und der 
TAP-abhängige (Transporter assoziiert mit Antigen Prozessierung) Weg. Die Signifikanz 
dieser Prozesse in vivo ist jedoch noch unklar.  
In dieser Arbeit untersuchen wir Macroautophagie (im folgenden als Autophagie bezeichnet) 
im Thymusepithel und ihre Bedeutung für die Entwicklung von T-Zellen näher. Autophagie ist 
ein evolutionär konservierter Prozess, der das Recycling langlebiger, zytoplasmatischer 
Proteine und Organellen ermöglicht. Autophagosomen schließen Zellbestandteile ein, 
verschmelzen mit späten Endosomen oder Lysosomen und liefern so intrazelluläre Antigene 
in das MHC II Kompartment.  
Wir konnten zeigen, dass TEC, im Vergleich zu anderen Körperzellen, eine hohe, 
konstitutive Autophagierate aufweisen. Genetische Manipulation der Autophagie in TEC 
führte zu einer veränderten Positivselektion bestimmter MHC II restringierter T-Zell 
Spezifitäten, ohne die Selektion von MHC I restringierten T-Zellen zu beeinflussen. 
Athymische nude/nude Mäuse, denen ein Autophagie-defizienter Thymus transplantiert 
wurde, entwickelten schwere Colitis und wiesen Infiltrationen verschiedener Organe mit 
Lymphozyten auf. Aufgrund dieser Erkenntnisse glauben wir, dass Autophagie intrazelluläre 
Antigene für die Beladung von MHC II Molekülen in TEC bereit stellt und dadurch 
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maßgeblich zur Effizienz der Positivselektion beziehungsweise Toleranzinduktion reifender 
CD4 T-Zellen beiträgt. 
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1. Introduction 
 
1.1      T cell Development 
1.1.1   Overview  
T cells are the main mediators of adaptive immune responses, thus the development 
of a functional and self tolerant repertoire of T cells is imperative for every healthy 
individual. Within the pool of mature T cells one can distinguish a number of different 
T cell subsets, each committed to a specialized function, that all together work in a 
synchronized way to efficiently eradicate different types of infections. The common 
characteristic of all T cells, regardless of their functional specialization, is the 
expression of a T cell receptor (TCR) on the cell surface. Virtually every single T cell 
expresses a unique TCR, hence in the mature T cell pool the repertoire of TCRs is 
highly diverse. This feature has evolved to enable the organism to fight the plethora 
of pathogens that one is likely to encounter during the life span. TCRs are not germ-
line encoded, as it would take a whole genome just to transmit the genetic 
information for all the different TCRs found on the surface of T cells. Instead, T cell 
receptors are formed through a process of random somatic rearrangements of a 
diverse repertoire of gene segments, a process which is ultimately linked to T cell 
development, maturation and survival. The TCR receptor recognizes a complex 
consisting of a self MHC molecule (for Major Histocompatibility Complex) and a 
bound peptide (MHCp).  
Unlike most of the hematopoietic cell types whose development takes place in the 
bone marrow, the vast majority of circulating T cells differentiates and maturates in 
the thymus, hence the abbreviation “T”. The thymus is compartmentalized into the 
cortical and medullary region and different cell types, i.e., cortical thymic epithelial 
cells (cTEC), medullary thymic epithelial cells (mTEC), dendritic cells (DC), 
macrophages (MΦ), B cells, fibroblasts and endothelial cells, form an unique three 
dimensional environment which supports distinct steps in T cell development1,2. T cell 
precursors, commonly known as common lymphoid progenitors (CLPs) enter the 
thymus via the blood stream at the cortico-medullary junction3. In the thymus, a 
highly complex course of proliferation, maturation and selection events takes place 
which results in the generation of a functional and self tolerant T cell repertoire. 
INTRODUCTION                                  
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However, T cell maturation is an extremely wasteful process, as more than 95% of 
thymocytes die during selection events on their journey through the thymus4. Thus, 
proliferation of immature thymocytes has an essential role in providing a large 
number of cells on which the rigorous selection processes function5.  Such a process, 
demanding an enormous amount of energy and resources, is the evolutionary price 
that vertebrates have paid for having an immune system that is, at the population 
level, able to combat billions of different pathogens. Due to the random nature of 
TCR gene rearrangements a high number of dysfunctional or useless TCRs is 
formed. The process of positive selection ensures that only those T cells that express 
a TCR that is able to recognize self MHCp complexes with sufficient affinity, are 
allowed to survive. Furthermore, mechanisms of central tolerance are ensuring that 
positively selected thymocytes, which harbor potentially self-reactive TCRs, are 
either deleted or deviated into the regulatory T cell (Treg) lineage. However, central 
tolerance induction is not fail-safe, and indeed self-reactive T cells can be found in 
the periphery of any individual6. Importantly, Treg cells are keeping self-reactive T 
cells in the periphery in check. Furthermore, mechanisms of peripheral tolerance 
synergize with Treg mediated control of self-reactive T cells to prevent the 
development of autoimmunity. Thus, one can think of positive selection and central 
tolerance mechanisms as an evolved quality control system that ensures that only 
those T cells that express functional and self-tolerant TCRs are allowed to leave the 
thymus and seed the periphery. 
 
1.1.2 Early events in T cell development and Positive selection 
 
From the very moment when CLPs enter the thymus at the cortico-medullary junction 
the fate of the developing thymocytes is determined by soluble factors and cell-cell 
interactions. When T cell precursors seed the thymus their TCR gene segments are 
in a germ line configuration. The most immature population of thymocytes is 
generally defined as double negative (DN) or pro-T cells, which reflects the fact that 
they still do not express the co-receptor genes CD4 and CD8 which cooperatively 
with TCR bind to conserved regions of MHC class II and MHC class I molecules, 
respectively7,8. The DN thymocytes migrate from the cortico-medullary junction 
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towards the outer cortex9 and during migration through the thymic tri-dimensional 
meshwork, DN cells are induced to start the process of somatic gene 
rearrangements10. Concomitantly with migration and maturation of DN population the 
changes in expression pattern of cell surface molecules (CD44 and CD25) take place 
on the basis of which the DN maturation process can be monitored. Accordingly, the 
DN cohort of thymocytes can be subdivided into four stages of differentiation: DN1 
(CD44+CD25-), DN2 (CD44+CD25+), DN3 (CD44-CD25+) and DN4 (CD44-CD25-)11. It 
is predominantly at the DN3 stage when pro-T cells start rearranging the TCRβ locus 
and pass through the first developmental check point called “β selection”. The TCRβ 
locus consists of a variable (Vβ), diversity (Dβ), joining (Jβ) and constant (C) gene 
segments. It is the VDJ region of the TCRβ locus that encodes for the variable region 
of the TCRβ chain that forms the ligand binding domain, while the constant gene 
segments encode for the transmembrane regions and short cytoplasmic tails of TCR. 
The V, J and D segments are encoded by numerous genes that are randomly 
rearranged and form the variable VDJ part of TCRβ chain. The high number of gene 
segments encoding for the ligand binding domain of TCR is the major source of TCR 
receptor diversity that is found in the T cell pool. The somatic rearrangement of TCR 
gene segments is facilitated by the action of recombination activating gene (Rag) 
proteins12-14. Once the TCRβ chain is assembled, it pairs with the pre-TCRα chain 
and CD3 to form a pre-TCRα complex at the cell surface15. Here, the TCRβ chain is 
checked for its usefulness, i.e., productive rearrangement of VDJ gene segments.  In 
the absence of signaling though pre-TCRα complex pro-T cells die by apoptosis. 
However, if developing thymocytes receive a signal during the process of β selection 
a number of changes will occur. The expression of Rag genes becomes down-
regulated and subsequently chromatin remodeling at the second TCRβ locus is 
taking place, which results in allelic exclusion16. Allelic exclusion ensures that every 
given T cell expresses only one TCRβ chain.  Furthermore, cells undergo extensive 
proliferation and at the late DN3 and DN4 stage in development start to rearrange 
their TCRα loci. However, it is in the DP stage that full-scale rearrangements on the 
TCRα locus take place17. Unlike the TCRβ locus, TCRα consists of numerous Vα and 
Jα gene segments, but lacks the diversity genes. The rearranged TCRα chain pairs 
with TCRβ to form a full TCR that is expressed on the cell surface. At this point or 
slightly earlier, developing T cells also start expressing their co-receptor genes, CD4 
and CD8, to become double positive cells (DP) that comprise ~90% of all 
INTRODUCTION                                  
9 
 
thymocytes18. The DP cells migrate from the outer regions towards the deep cortex 
and interact with MHCp complexes that are displayed by thymic stromal cells. 
Numerous in vitro and in vivo studies have come to the conclusion that cTEC play an 
indispensable role in positive selection of developing T cells19-23. The newly 
assembled TCR is checked for its functionality and self-MHC restriction during the 
process of positive selection. In its essence, positive selection is the process 
whereby T cells that harbor TCR that react with adequate, low affinity with self MHCp 
complexes displayed by cTEC receive a survival signals and are allowed to proceed 
with development. In the absence of survival signals from the TCR complex 
immature T cells die via apoptosis, which is generally called the death by neglect 
pathway to highlight the absence of TCR signaling due to an inability of the receptor 
to recognize the ligand, i.e., a self MHCp complex23,24. It is estimated that around 
90% of developing thymocytes undergo the death by neglect pathway25. However, 
allelic exclusion on TCRα locus is not as stringent as in the case of TCRβ locus26. 
Namely, DP T cells that express “useless” TCRs do not down-regulate RAG protein 
expression. Consequently, immature thymocytes can undergo several rounds of TCR 
gene rearrangements at the TCRα locus which increases the probability of 
generating a functional TCR during the life span of DP thymocytes.   
Concurrent with positive selection, DP cells differentiate to become CD4 or CD8 
single positive thymocytes, depending on the ability of their TCR to bind to MHCII/p 
or MHC class I/peptide (MHCI/p) complexes, respectively. Several theories have 
been put forward explaining how the “CD4 versus CD8” decision is made, but the 
current set of experimental data strongly supports the “signal strength” model of 
CD4/CD8 lineage commitment. The “signal strength” model states that the duration 
and/or intensity of signaling through the TCR complex dictate the CD4 versus CD8 
lineage choice, i.e., has an instructive role. Thus, stronger signaling results in CD4 
lineage commitment, while weaker interactions lead to differentiation into the CD8 
lineage9.   
1.1.3   Central tolerance 
A question that has captured immunologists for decades was how the immune 
system is able to combat a plethora of pathogens while at the same time it remains 
non-reactive to self. It was in 1959, when Burnet put forward a visionary concept 
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addressing this issue, the so called “clonal selection hypothesis”. The hypothesis 
states that lymphocytes specific for self antigens are eliminated from the repertoire to 
prevent autoimmune hazard27. A long history of research has proven Burnet´s 
hypothesis to be correct. The “elimination” of autoreactive lymphocytes, as proposed 
by Burnet, is implicated in the process of clonal deletion or negative selection which 
is a recessive mechanism of tolerance induction whereby developing T cells 
expressing a TCR that reacts with high affinity with self-MHC complexes will die by 
induced apoptosis28-30.  
However, in the late eighties seminal work from the Le Dourain lab has convincingly 
implicated the existence of dominant tolerance mechanisms operating in the thymus. 
An elegant set of experiments has shown that simultaneous transplantation of 
embryonic thymi and limb buds from quail into chicken embryos induced the 
acceptance of the transplanted limb, while the transplantation of a limb bud alone led 
to rejection of the graft. In this set up, embryonic thymi were grafted before 
colonization by hematopoietic precursors which highlighted the importance of the 
thymic epithelium in central tolerance induction. In such chimeras, T cells can be 
educated on either the endogenous or the transplanted quail thymus, but a recessive 
mechanism of tolerance operating in the quail thymus could not explain the observed 
phenomenon of limb acceptance. The findings argued that a transplanted quail 
thymus has the capacity to induce development of a special type of T cells with the 
ability to keep “xeno-reactive” T cells of recipient origin in a quite state31,32.  The 
authors went on to show that such cohort of T cells which is able to act  “in trans” and 
suppress the activity of graft-specific cells indeed exists in the periphery of chimeric 
animals by performing T cell transfer experiments33,34. In the years that followed the 
initial discovery of T cells with a regulatory function (hereafter referred to as Treg), 
Sakaguchi and colleagues have been able to show that cells mediating dominant 
tolerance are essential for prevention of autoimmunity, that the thymus is 
indispensable for the development of Treg and finally identified CD4SP cells which 
constitutively express the IL-2 receptor α chain (CD25) as a cell type capable of 
mediating suppression35-37. More recently, the transcription factor FoxP3 has been 
proposed to be the master regulator of Treg development38-40. Indeed, mice and 
humans carrying a mutation in the gene encoding FoxP3 suffer from severe 
autoimmunity due to a lack of Treg41,42. Taken together, the described studies on 
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Treg have convincingly shown that dominant tolerance induced in the thymus is an 
indispensable component of a healthy immune system. 
Until a few years ago, it was generally accepted that recessive and dominant 
mechanisms co-operatively work in the thymus to induce the state of tolerance to 
ubiquitous and thymus-specific antigens, while different mechanisms of peripheral 
tolerance (i.e., clonal deletion and induction of anergy) keep the mature T cells 
reactive to tissue-specific antigens (TSA) in a silent state. Such distribution of labor 
between central and peripheral mechanisms of tolerance has proven not to be 
correct. The thymus has the capacity to express a wide range of TSA and in that way 
it synergizes with the peripheral tolerance machinery to ensure that the mature T cell 
pool of every individual is tolerant to self. This extraordinary feature of the thymus 
has initially been recognized as an artifact of transgenics, as it has been documented 
that tissue specific transgenic constructs are ectopically expressed in the thymus43-45. 
Later, Hanahan and coworkers reinterpreted these findings as an inherent 
characteristic of the thymus46. Finally, in a landmark study mTEC have been 
identified as the unique cell type capable of expressing a wide range of TSA in a 
promiscuous fashion, a feature that was not evident in cTEC or thymic DC47,48. 
Additionally, Kyewski lab went on to show that the expression of a particular TSA is 
not found in every single mTEC, but it is rather restricted to 1-3% of total mTEC 
population, suggesting that it is all mTEC together that collectively build up a mosaic 
of the peripheral self in the thymus (“immunological homunculus”)47,49. MTEC appear 
to be a highly heterogenous group of cells, not only with the respect to the TSA 
profile that a particular mTEC expresses, but also based on surface expression 
levels of molecules involved in antigen presenting, i.e., MHC class II and  CD8050,51. 
Thus, one can distinguish two subpopulations of mTEC: mTEClo and mTEChi 
expressing low to intermediate and high levels of MHC class II and co-stimulatory 
molecules, respectively. Curiously, the widest range of TSA expression is found 
within the subpopulation of cells that has antigen presentation characteristics of 
professional APC, i.e., mTEChi 4,47,48.  It has been proposed, and recent evidence 
points to that direction, that mTEChi are the most mature, terminally differentiated 
subset of mTEC with a high turn-over rate52,53. Although the phenomenon of 
promiscuous gene expression has fascinated many scientists, the regulation of this 
process still remains a puzzle. So far only one regulator that is essential for the 
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expression of some, but not all TSA has been identified, the Autoimmune regulator 
(Aire)54. The significance of Aire-driven promiscuous gene expression in mTEChi in 
central tolerance is highlighted by the fact that both mice and humans deficient for 
AIRE suffer from organ-specific autoimmunity54, 55,56. 
While it is perfectly clear that both negative selection and induction of Treg are vital 
for the establishment of tolerance to self, the respective contribution of different cell 
types to tolerance induction is still a matter of intensive research. Studies on mice 
with impaired development and/or organization of the medulla revealed its crucial 
role in tolerance induction. Thus, in Rel-B, lymphotoxin-β receptor and TRAF6 
deficient mice the medullary compartment is altered, which results in the 
development of autoimmunity57-58,59. Furthermore, inhibition of thymocyte homing to 
the medulla in CCR7 and CCR7L deficient mice results in the break-down of central 
tolerance60. Taken together all these studies argue that the medulla plays a vital role 
in tolerizing the developing T cell repertoire; however the respective roles and overall 
input of mTEC and DC in clonal deletion and Treg induction is still unclear. Initial 
experiments have documented that 50% of positively selected thymocytes are 
eliminated from the developing repertoire by hematopoietic cells (most likely DC)61. 
However, mTEC have also tolerogenic potential, as T cells educated in the thymus 
where MHC class II expression is abrogated in hematopoietic system do not cause 
graft-versus-host disease when transferred into the lymphopenic host, while targeted 
deletion of MHC class II locus in both mTEC and DC leads to the development of a 
self-reactive T cell repertoire62,63. Furthermore, TSA antigen expression in mTEC is 
absolutely necessary for the establishment of tolerance towards peripheral 
antigens54. There are two mutually non-exclusive schools of thoughts explaining how 
TSA are actually presented to developing thymocytes. There is evidence arguing for 
cross-presentation of mTEC expressed antigen by DC, a scenario that implies that 
mTEC basically function as a reservoir of antigens that DC pick up for presentation to 
developing T cells. Indeed, a study with a TCR transgenic system revealed that DC 
mediated cross-presentation of mTEC derived antigen is necessary for deletion of 
auto-reactive CD4SP T cells. On the other hand, in the very same model deletion of 
CD8SP cells has been shown to be mediated by mTEC and DC64. The second theory 
states that mTEC express and autonomously present the antigens to developing T 
cells, and in that way directly contribute to the induction of tolerance. The deletion 
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potential of mTEC has been described in a system where the expression of 
transgenic human C-reactive protein (hCRP) was limited to 1-3% of mTEC. Using 
TCR transgenic animals specific for hCRP (Dep TCR transgenic) the authors 
documented that mTEC are able to autonomously delete hCRP specific thymocytes 
when the antigen is endogenously expressed49. Moreover, our lab has recently 
revealed that Aire-driven expression of cognate antigen in mTEC results in deviation 
of antigen specific T cells into Treg lineage and importantly mTEC mediated 
presentation of the antigen alone is sufficient for the induction of Treg phenotype65.  
Hence, mTEC have the capacity to process and present antigens to CD4 T cells 
which results in tolerance induction. It is still unclear if mTEC are dedicated “Treg 
inducers” or DC can also induce the deviation of self-reactive T cells into the 
regulatory lineage. There are studies stating that in humans DC can induce a Treg 
phenotype upon exposure to thymic stromal lymphopoietin (TSLP)66. It seems highly 
plausible that mTEC and DC can mediate negative selection and induce the 
deviation into the Treg lineage of self-reactive thymocytes. 
Studies discussed above imply that the medulla plays an indispensable role in central 
tolerance, but the exact contribution of the cortex in tolerance induction is still a 
matter of debate. First reports on negative selection in TCR transgenic systems, 
where the fate of T cells specific for either endogenous antigen or an antigen 
expressed as a transgene has been followed, revealed that the self-reactive T cells 
are eliminated from the repertoire at the early stages of development, i.e., at the DN 
or DP stages29,67-69. Apart from deletion, other mechanisms of tolerance induction 
have been ascribed to cTEC, such as receptor editing. Namely, one study has 
suggested that upon the encounter with cognate antigen which is expressed in cTEC, 
self-reactive T cells down-regulate the expression of the TCRα chain which is 
followed by increased frequency of recombination on endogenous TCRα loci. Pairing 
of the newly rearranged TCRα chain with the transgenic TCRβ chain results in the 
generation of a novel TCR specificity70. However, as it will be discussed later on, T 
cells that express two TCRs on the cell surface may increase the chance of 
development of autoimmune diseases, thus the significance of receptor editing in 
establishing tolerance to self is questionable. Furthermore, two studies have 
implicated cTEC as mediators of dominant tolerance induction71,72. However, in 
studies of Bensinger et al. and Liston et al. cTEC specific MHC class II expression on 
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MHC class II null background was driven by K14 promoter. In this set up, the 
expression of MHC class II on mTEC has not be formally excluded, which is an 
important issue considering the fact that K14 is a marker keratin for mTEC on one 
hand, and inherent capacity of mTEC to promiscuously express TSA on the other. 
Furthermore, in our hands K14 driven expression of a transgene led to a detectable 
expression of protein in mTEC (unpublished observation).  
Taken together, numerous reports indicated that cortex contributes to the 
establishment of central tolerance. However, the cortex does not have a capacity to 
induce complete non-reactivity to self, as T cells educated in the thymus where 
mTEC and DC cannot present antigens are self-reactive63,73. At this point, it is 
reasonable to assume that tolerance to ubiquitous antigens that are expressed at 
high levels in the cortex can be mediated by cTEC, hence a minor population of self-
reactive T cells could get eliminated from the repertoire at the early stages of 
development.  
Every single step in the development and life of T cells critically depends on the 
interaction of the TCR with MHCp complexes displayed by APC. Thus cell biology of 
antigen processing and respective MHC class I and MHC class II loading pathways 
have occupied attention of immunologists for decades. At present, the cellular 
machinery involved in antigen processing is fairly well understood, however new 
concepts of antigen processing are emerging which are bringing the field of antigen 
presentation back to the focus of immunological research. In the following 
paragraphs the old and new concepts of antigen processing and presentation with a 
particular accent on evolutionary specializations of TEC will be discussed. 
 
1.2 Cell Biology of Antigen Processing 
 
1.2.1 Classical MHC class I and class II antigen loading pathways 
One of the landmark discoveries in immunology the significance of which cannot be 
highlighted enough was the elucidation of the crystal structure of the MHCI/p 
complex74. Subsequently, the crystal structure of MHCII/p complex has been 
resolved as well75. Thus, the work from the Wiley lab have paved the way to better 
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understanding of molecular mechanisms involved in antigen presentation and the 
basis of TCR/MHCp complex interactions. These studies revealed that MHC class I 
and MHC class II molecules share several structural features, i.e., both molecules 
are transmembrane proteins, consisting of an extracellular peptide binding cleft 
followed by a pair of immunoglobulin-like domains and a transmembrane region. 
MHC molecules are highly polymorphic, and the polymorphism is found in and 
around the region that forms the peptide binding groove. It is the polymorphism in the 
peptide binding cleft that allows one MHC molecule to bind to the diverse set of 
peptides, but on the other hand only the peptides that have features allowing 
complementary interactions with MHC peptide binding pockets can be found on a 
particular allelic version of a given MHC molecule.  
The MHC class I molecule is expressed on all nucleated cells in the body. A highly 
polymorphic MHC class I α chain (heavy chain) non-covalently interacts with the 
soluble protein β2-microglobulin (light chain, β2m) to form an “empty” MHC class I 
molecule. Unlike the α-chain, β2m is non-polymorphic and does not contribute to the 
formation of the peptide binding groove. The peptide binding cleft of the MHC class I 
molecule is in a “closed” conformation and allows for the binding of peptides that are 
8-11 amino acids long74,76. Furthermore, peptides with C-terminal hydrophobic 
residues are preferentially found in a complex with MHC class I due to the specificity 
of the anchor pockets in the peptide binding groove. Both chains are synthesized in 
the endoplasmic reticulum (ER) where they are folded into a proper conformation 
with the help of ER-resident chaperones, such as calreticulin and calnexin77,78,79.  It is 
also in the ER where peptide binding takes place, and only MHC class I molecules 
with bound peptide are structurally stable. Thus, one should envision MHC class I 
molecule as a hetero-trimeric complex, consisting of an α-chain, β2m and the 
peptide.  
The peptides bound to MHC class I molecules are generated by the proteolytical 
activity of intracellular proteases, with the proteasome playing the essential role in 
epitope generation. MHC class I molecules are loaded with epitopes that originate 
from cytosolic and nuclear proteins. The proteasome is a house-keeping protease 
expressed in all somatic cells responsible for the degradation of ubiquitinylated 
proteins, accumulation of which results in cytotoxicity. It is a multimeric complex 
composed of a 20S barrel-like structure which is the catalytically active subunit. It 
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associates with the “cap”-like regulatory subunit 19S, which is responsible for the 
recognition and unfolding of ubiquitinylated complexes. The catalytic subunit consists 
of four heptameric rings, α(1-7)β(1-7)β(1-7)α(1-7) and the hydrolytic activity is conferred to 
the β1, β2 and β5 subunit. The respective hydrolytic activities of the β subunits can 
be described as a caspase-like (cleaving after acidic residues), trypsin-like (cleaving 
after basic residues) and chymotrypsin-like (cleaving after hydrophobic residues). 
Quite elegantly, the immune system has adapted the basic cellular catabolic 
machinery for the generation of MHC class I peptide epitopes. Furthermore, in APC a 
specific isoform of the proteasome is expressed, the so called “immunoproteasome” 
to distinguish it from a house-keeping form, where the constitutive β subunits are 
replaced with “immunosubunits” LMP2 (β1i), LMP7 (β5i) and MECL1 (β2i). The 
hydrolytic subunits of the “immunoproteasome” have a specialized feature that allows 
for the generation of peptides with characteristics that are best suited for the binding 
to the MHC class I peptide cleft. The proteolytic activity of LMP2, LMP7 and MEL1 is 
chymotrypsin- and trypsin-like which leads to the generation of peptides with basic 
and hydrophobic amino acids at the C-terminus80. In the primary and secondary 
lymphoid organs, i.e., thymus and spleen, “immunosubunits” are constitutively 
expressed81. The analyses of LMP2 and LMP7 knock out mice have revealed that 
CD8 T cell repertoire is impaired, confirming the indispensable role of the 
“immunosubunit” mediated epitope generation for the development of a fully 
functional immune system82. Additionally, IFNγ can induce the expression of 
“immunosubunits” at the site of inflammation83.  
It has recently been shown that cTEC express a specific proteasomal catalytic 
subunit: thymus specific β5 family member (β5t)84. The so called “thymoproteasome”  
has a reduced chymotrypsin-like activity, which raises the possibility that MHC class I 
peptide epitopes generated in cTEC are different from those generated by 
constitutive proteasomes and “immunoproteasomes”. On the other hand it has been 
shown that the thymic stromal cells implicated in negative selection, mTEC and DC, 
rely on “immunoproteasomal” activity for the generation of MHC class I epitopes81. 
The expression profile of catalytic proteasomal subunits implies that the repertoire of 
MHCI/p complexes displayed to developing CD8 T cells in the cortex and medulla 
might be qualitatively and/or quantitatively different. Importantly, β5t deficient mice 
display significantly reduced numbers of CD8SP, while CD4SP T cell development 
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appears not to be impaired. The authors suggested that the block in CD8SP T cell 
development results from impaired positive selection due to an alteration in the 
MHCI/p repertoire in β5t-/- cTEC. However, the hypothesis awaits its formal 
verification.  
MHC class I molecules are loaded with peptides originating from intracellular and 
nuclear proteins. Proteins are marked for proteasomal degradation by ubiquitination, 
a signal that is specifically recognized by the regulatory subunit of the proteasome. 
Moreover, accumulating evidence in the literature suggests that MHC class I peptide 
epitopes actually originate from defective ribosomal products (DRiPs). DRiPs are 
ubiquitinylated polypeptides that are generated as a result of an inaccurate and/or 
premature termination of mRNA translation85-88. The recent decoding of the human 
and mouse genome will allow for the precise assessment of the origin of MHC class I 
bound peptides, i.e., if they originate from “out of frame” translational products or fully 
assembled functional proteins in the cell.  
Whatever the source of the MHC class I epitopes is, proteins and/or DRiPs, after 
proteasomal degradation the peptides are shuttled to the ER via the transporter 
associated with antigen processing (TAP). TAP is a transmembrane heterodimer 
consisting of TAP.1 and TAP.2 subunits and it is located in the ER membrane. The 
capacity of TAP to translocate peptides across the ER membrane has initially been 
indicated in mice with a targeted deletion of the TAP locus89   and subsequently the 
mechanism of translocation has been elucidated in in vitro experimental set 
ups90,91,92. Apart from its role in peptide translocation, TAP is associated with the ER 
resident chaperone calreticulin which in turn binds to and stabilizes the “empty” MHC 
class I molecule. The association of TAP and calreticulin is mediated by the 
chaperone tapasin79. The topology of this supra-molecular complex allows for the 
efficient binding of imported peptides to the groove of MHC class I molecules. Further 
trimming of epitopes takes place in the ER via the action of ER-resident 
aminopeptidases93. This process ensures the generation of peptides that are 8-11 
amino acids in length and thus display the structural features favorable for binding to 
the MHC class I cleft. Upon binding of peptides, stable MHCI/p complexes are 
transported from the ER via the Golgi apparatus to the cell surface for display to CD8 
T cell (Graphic 1).  
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Graphic 1. MHC class I loading pathway. Intracellular proteins are targeted for 
proteasomal degradation by ubiquitination. Subsequently, peptides are transported from the 
cytosol to the endoplasmic reticulum (ER) via transporter associated with antigen processing 
(TAP). The stable peptide bound MHC class I complexes are transported to the cell surface 
by exocytic vesicles. 
The above described model of MHC class I antigen loading was called into question 
by the finding that DC are able to present extracellular antigens derived from 
surrounding  cells on MHC class I molecules and prime naive CD8 T cells during 
adaptive immune responses94,95,96. Thus, it became clear that the topological rules for 
MHC class I antigen loading are not as strict as it has previously been appreciated. 
The underlying mechanism explaining a phenomenon of so called “cross-
presentation” is still a matter of intensive debate in the field. Several groups have 
described a model whereby internalized extracellular proteins can actively be 
transported from the endosomal compartment to the cytosol via (i) the action of a 
specific transporter protein or (ii) a poorly defined “leakage” from endosomes97. Once 
in the cytosol, the polypeptides can gain access to the MHC class I loading route 
after proteasomal processing and TAP-mediated translocation to the ER. However, 
the studies relying on the specific inhibition of proteasomal activity and/or TAP 
function in the phenomenon of “cross-presentation” should be carefully interpreted, 
as MHC class I expression levels in such experimental set-ups are reduced due to 
inefficient peptide loading.  Recently, Neefjes and colleagues have put forward the 
“antigen spreading model hypothesis”  that recognizes the role of gap junctions in 
intercellular transfer of peptides98. They presented conclusive evidence that antigen 
proteasome
TAP
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synthesized in one cell can be transferred through gap junctions to the neighboring 
cell and presented on MHC class I via the classical MHC class I loading pathway. 
This model postulates that virus-infected or tumor cells may form intercellular 
connection channels with DC and in that way pass the information of “what is going 
on” in the cell. Such a sequence of events would ultimately allow for “cross-priming” 
of naive CD8 T cells. Nevertheless, the in vivo significance of gap junctions remains 
to be elucidated. It is, however, worth mentioning here that some groups of viruses 
have evolved specialized strategies that allow them to block the formation of gap 
junctions in infected cells99,100. It seems plausible that by doing so viruses can block 
“cross presentation” as yet another strategy of immune evasion. 
Unlike MHC class I, MHC class II molecules are constitutively expressed only on 
professional APC, i.e., DC, B cells, macrophages and importantly on cTEC and 
mTEC. Thus, TEC are the only non-hematopoietic cell types that constitutively 
express MHC class II. Furthermore, MHC class II expression can be induced on 
fibroblasts, endothelial and epithelial cells at the site of inflammation in response to 
inflammatory cytokines, such as IFNγ.  
The MHC class II molecule is a heterodimer consisting of two polymorphic 
polypeptide chains, MHCII-α and MHCII-β. These molecules are synthesized in the 
ER and assembled by the help of ER-resident chaperone proteins, such as 
calnexin101. The assembly of MHC II-α with the β chain results in the formation of the 
peptide binding groove which  unlike in the case of MHC class I, is in an “open-end” 
conformation and can accommodate peptides that are 10-30 amino acids long75, 102-
104. The premature binding of peptides to the MHC class II molecules in the ER is 
prevented by co-synthesis of the third component of an “immature MHC class II 
complex”, the invariant chain (Ii). It is the CLIP region (for class II associated 
invariant chain peptide) of Ii that firmly associates with the MHC class II binding 
groove105,106. Moreover, Ii contains an endosomal localization sequence which 
enables targeting of newly synthesized MHCII/Ii heterotrimers to the 
endosomal/lysosomal compartment107-110. In the late endosomal compartment newly 
synthesized MHC class II molecules meet with the machinery involved in antigen 
processing and MHC class II loading, more commonly known as MIIC ( for MHC 
class II containing compartment)111. During trafficking to the late 
endosomal/lysosomal compartment, degradation of Ii chain takes place in a stepwise 
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fashion, and the MHC class II groove remains occupied by CLIP. Subsequently, the 
molecular chaperone H-2M catalyzes the dissociation of CLIP, stabilization of an 
“empty” MHC class II molecule and the loading of peptides to the peptide-binding 
groove112-114 (Graphic 2). The H-2M molecule shows a notable structural homology to 
the MHC molecule itself, but unlike MHC II, H-2M is non-polymorphic. It is difficult to 
give an exact definition of the MIIC, however electron-microscopy studies have 
identified MIIC as a MHC-rich compartment with multilamellar appearance115 and a 
consensus has emerged in the field that MIIC is the late endosomal compartment 
supplied with the machinery for efficient antigen loading116,117. 
 
Graphic 2. Classical MHC class II loading pathway. Extracellular antigens are captured 
and internalized into endosomes by APC; subsequently endosomes fuse with lysosomes 
which deliver proteases involved in antigen processing. On the other hand, MHC class II 
molecules are synthesized in the ER where they associate with invariant chain (Ii). Upon 
synthesis, MHC class II/Ii complexes are transported to the MHC class II loading 
compartment (MIIC) where they fuse with late endocytic vesicles containing processed 
antigens. Ii gets degraded and the remaining CLIP fragment occupies the peptide binding 
cleft of MHC II. The molecular chaperone H-2M catalyzes the exchange of CLIP with 
peptides derived from the late endosomal/lysosomal compartment. 
 
Cathepsins, lysosomal proteases, have been shown to play a non-redundant role in Ii 
processing. Remarkably, cTEC and bone marrow derived APC (DC, B cells and 
macrophages) show different enzymatic signatures with respect to cathepsin 
expression. Degradation of the Ii chain in cTEC is critically dependent on Cathepsin L 
(CatL) activity. Thus, CatL deficient mice show accumulation of Ii chain degradation 
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intermediates, decreased repertoire of MHCII/p complexes as judged by an increase 
in MHCII/Ii derived peptide complexes on the cell surface and reduced numbers of 
CD4 cells in the thymus and in the periphery118.  These findings implied that CatL 
plays an indispensable role in the MHC class II maturation in cTEC and in positive 
selection of CD4 T cells. On the other hand, Ii degradation in DC is mediated by 
Cathepsin S119-121. The involvement of different proteases responsible for MHC class 
II maturation in the cell types mediating positive and negative selection may imply 
that the peptide repertoires displayed to developing CD4 T cells in the cortex and 
medulla differ at least at the quantitative level, which stands in line with the discussed 
findings about the CD8 repertoire selection. This hypothesis is further supported by 
findings that a specific I-Ab/I-Eα(52-68) epitope is expressed at a lower level in cTEC 
then in DC122-124. The observations that indicate involvement of a similar set of 
proteases involved in antigen processing in the cell types mediating tolerance 
induction, i.e., mTEC and DC, and peripheral APC are intuitively understandable. 
Namely, in that way T cells can get checked for self-reactivity during their journey in 
the medulla to the very same peptide epitopes that they are exposed to in the 
periphery, and thus the autoimmune hazardous potential of mature T cell pool is 
minimized.  On the other hand, the biological significance of a potentially different 
ligandome on cells mediating positive selection remains to be established, though it 
may add to the hypothesis that signaling through the TCR differs at both the 
quantitative and the qualitative level during the process of positive and negative 
selection. However, sequence analyses of peptides eluted from cTEC and peripheral 
APC did not reveal any major differences in the composition of respective MHCII/p 
repertoires125. Still, one has to keep in mind that the sensitivity of the techniques 
used for MHC class II ligandome analyses might not allow for detection of low 
abundance peptides that add to the diversity of a MHCII/p repertoire. 
The trafficking pattern of MHC class II molecules determines the source of peptides 
that is presented to CD4 T cells. As outlined above, “mature” MHC class II molecules 
meet up on their route to the cell surface with late endosomes, and it is the late 
endosomal compartment of APC where MHC class II peptide loading occurs 
(Graphic 2). Professional APC, such as DC, are equipped with machinery that allows 
for efficient sampling of exogenous and cell membrane associated antigens by the 
process of pinocytosis, receptor mediated endocytosis and/or phagocytosis126, 127. 
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The early endosomes subsequently fuse with the lysosomal compartment which is 
rich in hydrolytic enzymes and these fusion events ultimately result in the 
degradation of the ingested extracellular cargo. Thus, MHC class II molecules are 
primarily loaded with peptides originating from the extracellular and cell-membrane 
associated proteins127.   
At this point, much remains to be learned about the specific proteases involved in 
protein processing and peptide generation in the MHC class II loading pathway. The 
lysosomal proteases are the main candidates, as pharmacological inhibition of 
lysosomal activity results in diminished antigen presentation126. Indeed, in bone 
marrow derived APC asparagine endopeptidase has been shown to play a crucial 
role in degradation of microbial antigens128. However, the identity of enzymes 
involved in generation of MHC class II epitopes in thymic stromal cells is still awaiting 
its discovery. Follow up studies with CatL deficient mice have implicated CatL in 
degradation of proteins in the  MHCII pathway, as CatL, Ii double knock out animals 
have a more severe block in positive selection of CD4 T cells then either of the single 
knock out animals129,130. The authors speculated that the underlying reason for the 
observed phenotype is a reduced diversity of MHCII/p complexes displayed by CatL-/-
, Ii-/- cTEC, though the direct proof for this hypothesis is still missing. 
After binding of peptides to MHC class II molecules, the MHCII/p complexes are 
transported to the cell membrane. However, the precise mechanism of the MHCII/p 
complex delivery from MIIC to the cell surface is still enigmatic. Recent evidence 
suggests that the late endosomal/lysosomal compartment forms tubule-like 
structures and subsequently vesicles enriched with MHCII/p complexes detach from 
the tubular protrusions and fuse with the cell membrane131‐132 .  
Intriguingly, while DC are highly proficient in sampling and presenting the 
extracellular milieu to developing T cells, the capacity of cTEC and mTEC to capture 
and/or process extracellular antigens has proven to be very low49, 133, 134. Thus, ex 
vivo isolated DC from mice intravenously injected with myoglobin efficiently 
presented the antigen to a specific T cell hybridoma, but only weak stimulation has 
been observed when cTEC and mTEC were used as APC. Studies in in vitro 
systems using cTEC lines have also come to the conclusion  that cTEC have a rather 
poor ability to present exogenous antigens135-137. These set of data prompted the 
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authors to speculate that cTEC and mTEC focus their attention on the intracellular 
compartment for the generation of ligands for MHC class II molecules. The so called 
“division of labor” hypothesis has been put forward which postulates that mTEC and 
DC present different set of peptides to developing T cells during their educational 
journey through the thymus. Being highly efficient in capturing extracellular antigens, 
DC would preferentially use the classical, endocytic route of MHC class II antigen 
loading and consequently the MHCII/p repertoire of DC would mirror blood-borne 
proteins in the thymus. On the other hand, mTEC would present the universe of 
intracellular self, which importantly comprises a wide array of tissue specific 
antigens138. The nature of endogenous loading pathway/s operating in cTEC and 
mTEC remained unknown at that point. Studies in in vitro systems have implicated 
several possible mechanisms for the shuttling of intracellular antigens to MIIC in 
different APC.  The nature of these endogenous MHC class II loading pathways will 
be subject of the following section. 
 
1.2.2 Alternative MHC class II antigen loading pathways 
 
Seminal work by Charles Janeway and his colleagues103, 139 provided for the first time 
precise characterization of physiologically produced peptides associated with MHC 
class II molecules in B-cell lymphoma lines. These so called ligandome analyses 
relied on immunoaffinity purification of MHC class II molecules followed by acid 
elution and sequencing of bound peptides. Subsequent refinement of technology 
allowed for a high through-put MHCII/p ligandome analyses which provided first 
experimental evidence that challenged the classical immunological dogma of MHC 
class II antigen loading102,140-142. Specifically, these studies estimated that around 
85% of peptides analyzed were derived from endogenous cellular proteins 
synthesized by APC itself. The vast majority of these endogenous peptides were 
derived from transmembrane or secreted proteins as well as proteins involved in 
MHC class II antigen processing.  This group of proteins traffics through the 
endocytic compartment and display of their respective epitopes on MHC class II 
molecules can be easily explained by classical antigen loading pathway. However, 
the source of around 20% of the identified epitopes are cytosolic proteins that 
INTRODUCTION                                  
24 
 
normally do not intersect the endocytic machinery, i.e., mitochondrial proteins (e.g. 
cytochrome b5 reductase), cytoskeletal proteins (γ- Actin, F-actin capping protein), 
metabolical enzymes (glyceraldehyde-3-phosphate dehydrogenase, GAPDH), 
chaperones (Hsc70), nuclear proteins (histones) to name a few102, 140. The 
presentation of epitopes derived from intracellular and organellar proteins by MHC 
class II is more difficult to explain by classical, endocytic antigen loading route. 
In parallel with the biochemical ligandome analyses several in vitro antigen 
presentation studies using human and murine APC in the early nineties have shown 
that the MHC classes II loading of ectopically expressed intracellular proteins does 
not require release and re-internalization of a model antigen, and consequently does 
not follow the endocytic route of antigen entry to the MIIC. These surprising findings 
revealed that MHC class II molecules sample both extracellular and intracellular 
pools of proteins for display to CD4 T cells. MHC class II– restricted endogenous 
antigen presentation has been so far documented for a wide array of different self 
antigens, model antigens, tumor and viral antigens, indicating that intracellular 
antigen loading is a phenomenon of a broad immunological significance143-144. 
Accordingly, the cell biology of intracellular antigen processing and endogenous 
MHC class II loading has become a field of intensive research during the last two 
decades. The experimental evidence coming from different laboratories revealed 
high complexity of cellular mechanisms involved in sampling of intracellular self for 
the presentation on MHC class II molecules. On the basis of these findings 
endogenous loading pathways can be grouped into two main categories. The first 
category can be defined as a TAP-dependent pathway which requires intracellular 
antigen processing by cytoplasmic proteases and subsequent import of protein 
degradation products to either ER or recycling MHC class II rich endosomes via the 
TAP molecule145,146 . The second category involves a rather heterogeneous group of 
intracellular processes collectively known as autophagy. 
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1.2.3 Autophagy as an endogenous antigen loading pathway 
The word autophagy originates from the ancient Greek and literally translates as self 
eating (auto=self, phage= to eat). There are three main autophagic pathways in 
higher eukaryotes that can deliver cytoplasmic constituents for lysosomal 
degradation: microautophagy, chaperone mediated autophagy and macroautophagy 
(Graphic 3). 
Microautophagy is a constitutively active process during which small portions of the 
cytosol are directly imported to the lysosomal lumen via membrane invaginations. 
The process has been studied mainly in yeast and cell free systems, and little is 
known about the molecular mechanism of microautophagy in mammals147,148. It is 
generally accepted that microautophagy is a constitutively active, nonselective 
catabolic pathway in the cell. To date, there is no experimental evidence implicating 
microautophagy in endogenous antigen loading, as the tools for targeted genetic 
disruption or pharmacological inhibition of the process are not available.  
Chaperone mediated autophagy (CMA) is a highly selective autophagic pathway 
that mediates the transport of proteins and peptides to the endosomal/lysosomal 
compartment149. A chaperone, heat shock cognate protein of 70 kDa (Hsc70), is one 
of the essential players in CMA that specifically recognizes proteins and peptides 
with a particular KFERQ-like pentapetide motif. Generally, exposure of this particular 
motif in proteins requires either proteolytical processing by cytoplasmatic proteases 
and/or conformational changes of the substrate. Once Hsc70 tags the target 
molecule, it facilitates its delivery to the late endosome/lysosome where a specific 
isoform of lysosome associated membrane protein 2 (LAMP2a) translocates the 
substrate150,151. The LAMP2a protein has been proposed as a rate limiting factor in 
CMA149, accordingly modulation of its expression level allows for experimental 
manipulation of CMA activity in the cell.   
The lab of Janice Bloom has recently elegantly shown an involvement of CMA in 
endogenous MHC class II loading. Over expression of Hsc70 or Lamp2a in B cell 
lines led to superior presentation of several epitopes derived from intracellular 
proteins to CD4 T cells, while down-regulation of CMA resulted in diminished antigen 
presentation152. An indirect evidence for participation of CMA in endogenous antigen 
loading comes from the analyses of MHC class II ligandome. GAPDH is a proposed 
INTRODUCTION                                  
26 
 
substrate for CMA153 and its specific epitopes have been identified as naturally 
occurring MHC class II ligands141. In this scenario, efficient presentation of 
intracellular antigens on MHC class II requires proteolytical processing of intracellular 
antigens by cytosolic proteases such as proteasome and/or calpain. The proteolysis 
of target proteins results in the exposure of a CMA specific pentapeptide targeting 
motifs that marks the peptide for delivery to late endosomes/lysosomes where the 
loading to MHC class II molecules takes place152,154.  
Even though the CMA pathway is a highly selective process, bioinformatical and 
biochemical analyses have shown that around 30% of intracellular proteins contain 
KFERQ-like sequence155. Thus the number of proteins that can be targeted for 
degradation via CMA is not negligible and consequently it can significantly contribute 
to the diversity of MHCII/p complexes in APC. Importantly, constitutive Lamp2a 
expression has been confirmed in a large panel of APC152.  However, the respective 
in vivo significance of the CMA pathway for endogenous MHC class II loading in CD4 
T cell development and adaptive immunity remains to be discovered. 
 
Graphic 3. Autophagic pathways: microautophagy, chaperone mediated autophagy 
(CMA) and macroautophagy. Microautophagy is characterized by direct lysosomal uptake 
of soluble cytoplasmic proteins. In chaperone mediated autophagy (CMA), LAMP2a and 
Hsc70 deliver cytosolic proteins to the lysosomal lumen. Macroautophagy sequestrates 
cytosolic components into autophagosomes and delivers the ingested cargo for lysosomal 
degradation. 
CMA
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Macroautophagy is genetically best characterized autophagic pathway in 
eukaryotes. The implication of macroautophagy in endogenous antigen loading has 
been intensively studied in different in vitro systems and our study focuses on the 
role of macroautophagy in thymic epithelium. Thus, the general physiological 
significance, molecular mechanism and its role in antigen presentation will be 
discussed in the following paragraph. 
 
1.3 Macroautophagy – process, function and role in endogenous antigen 
loading 
 
Macroautophagy (hereafter referred to as autophagy) is an evolutionary highly 
conserved catabolic process within the eukaryotic phylum, which is responsible for 
turnover of long lived cytoplasmic proteins and aged or damaged organelles. The 
process has originally been identified in rat hepatocytes in the early sixties as a 
cellular response to glucagon treatment and starvation156,157.  
During the process of autophagy de novo formation of vesicles is taking place, but 
the origin of the membrane still remains a mystery158, 159. In the initiation step of 
autophagy a small cup shaped structure, called isolation membrane or phagophore is 
formed, that engulfs cytoplasmic components which are to be degraded. The 
isolation membrane elongates to fuse its ends and forms an immature 
autophagosome. The autophagosome, which is the main organelle of autophagy, is 
characterized by the presence of a double membrane. It is a large organelle between 
0.5-1.5μm in diameter, depending on the organism and cell type160,161. 
Autophagosomes further fuse with endosomes to form mature autophagosomes or 
amphisomes162-164.  It is proposed that endosomes provide the required machinery 
for fusion of amphisomes with lysosomes. Lysosomes deliver hydrolases that 
degrade ingested cytoplasmic cargo together with the inner autophagic membrane. 
The autophagolysosome is the only catabolic vesicle in the process of 
autophagy165,166 (Graphic 4). The process is generally thought to be non selective, 
i.e., the isolation membrane randomly engulfs parts of the cytoplasm. However, 
recent studies have identified molecular players, such as p62/SQSTM1 
(sequestrosome) and Alfy (autophagy-linked FYVE protein) which are involved in the 
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selective degradation of ubiquitinylated proteins and inclusion bodies via 
autophagy167-168. Furthermore, a selective degradation of mitochondria (“mitophagy”) 
and invading bacteria (“xenophagy”) have been described in mammals169-171. The 
respective mechanism behind selective targeting of organelles for autophagosomal 
degradation is still ill defined. 
 
 
Graphic 4. The process of macroautophagy: an isolation membrane (1) enwraps a portion 
of cytoplasm and fuses its ends to form an autophagosome (2). Subsequently 
autophagosomes fuse with endosomes (3) and lysosomes (4) which results in the formation 
of autophagolysosome (5) where digestion of autophagic cargo is taking place. 
 
1.3.1   Molecular mechanism of autophagy  
 
Even though autophagy has been originally described in mammals more than five 
decades ago, the elucidation of the underlying molecular mechanism came from 
genetic screens in yeast during last two decades172, 173. Since then, we witnessed a 
real explosion of knowledge regarding the molecular mechanism, regulation and 
physiological significance of autophagy. To date there are around 30 genes identified 
in yeast that play an essential role in autophagy, collectively known as Autophagy 
related genes (Atg)174. Most of the identified genes in yeast are conserved in 
mammals. The vast majority of Atg genes are essential players in the initiation and 
elongation steps of autophagosome formation. They encode for proteins involved in 
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conjugation reactions, which resemble enzymatic reactions described for the 
ubiqutin-conjugation mechanism, hence the name ubiqutin-like (Ubl) conjugation 
systems. There are two Ubl conjugation systems involved in autophagosome 
formation: Atg5-Atg12 and Atg8-PE (phosphatidylethanolamine). Mammalian 
homologue of yeast Atg8 ubiquitin-like modifier is microtubule associated protein 1 
light chain 3 (MAP1-LC3, which will be referred to in the following as LC3). 
 
During the initiation phase of autophagosome formation an Ubl modifier Atg12 gets 
covalently coupled to the Atg5 protein. This conjugation reaction requires the activity 
of two enzymes Atg7 (E1-like activating enzyme) and Atg10 (E2-like conjugating 
enzyme) (Graphic 5). The resulting Atg5-Atg12 conjugate further non-covalently 
interacts with Atg16L1, and ultimately forms a multimeric complex, Atg5-Atg12-
Atg16L1, which is indispensable for the initiation and elongation phase of 
autophagosome formation175-176. The Atg5-Atg12-Atg16L complex is nonsimetricaly 
distributed on the phagophore and it primarily localizes to the outer leaflet of the 
membrane. Shortly before completion of autophagosome formation, the Atg5-Atg12-
Atg16L complex dissociates from the membrane and recycles to the cytoplasm. 
Importantly, targeting of LC3 to autophagosomal membranes is absolutely dependent 
on Atg5-Atg12 conjugation system and accumulating evidence suggests that Atg5-
Atg12-Atg16L1 complex acts as a docking site for the LC3 lipidation machinery160, 177-
178, 179. LC3 is synthesized as an inactive precursor form: Pro-LC3. The specific 
cysteine protease Atg4 cleaves pro-LC3 which leads to the generation of the 
cytoplasmic form, LC3-I. Upon induction of autophagy, Atg7 and Atg3 enzymes 
mediate LC3-I protein conjugation to PE in the autophagosomal membrane which 
finally results in the formation of an autophagy active form of the protein: LC3-II 
(Graphic 5).  This is so far the only known Ubl conjugation system that mediates 
protein lipidation180,181. Unlike Atg5-Atg12-Atg16L1 complex, the LC3-II protein is 
uniformly distributed on both inner and outer membrane and it does not dissociate 
from the autophagosomal vesicles until fusion with lysosomes takes place. 
Therefore, LC3 protein is considered to be a good autophagosomal marker. Upon 
formation of the autophagolysosome, the inner membrane associated LC3 portion 
gets degraded, while the cytosolically oriented LC3 is delipidated by Atg4 and 
released to the cytosol180, 182, 183 (Graphic 5). The LC3-PE conjugation system is 
essential for elongation and closure of the phagophore184. Notably, there are at least 
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two more LC3 homologues in mammals, GABARAP and GATE-16189,185-181, 186, 187. 
However, the respective role of these proteins in autophagy and possible redundancy 
in function of mammalian Atg8 homologues in autophagosome formation has still to 
be elucidated. 
a.                                                                b.  
 
Graphic 5. Ubiquitin like conjugation systems involved in autophagosome formation 
in mammals a. Atg5-Atg12 ubiquitin like system b. LC3-PE ubiqutin like system 
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1.3.2    Role of autophagy in mammals 
 
The most acknowledged role of autophagy is the supply of amino acids under 
nutrient-limiting conditions as exemplified by induction of autophagy under 
experimentally created starvation conditions156,161 and by neonatal lethality of 
autophagy deficient mice184,188,189,190. The neonatal lethality of autophagy deficient 
pups is caused at least in part by an inability to sustain energy homeostasis upon a 
sudden termination of nutrient supplies via the placenta, the unique problem that 
mammals face during their development.  
Apart from this evolutionary conserved role of “induced autophagy” as an adaptive 
response to starvation, the physiological significance of “constitutive” or basal 
autophagy which occurs even under nutrient rich conditions in the maintenance of 
cellular homeostasis has begun to be elucidated. Autophagy has been implicated as 
an important protein quality control mechanism in the brain and liver, as targeted 
ablation of autophagy in these organs resulted in the accumulation of toxic protein 
aggregates that ultimately led to the development of neurodegenerative disease and 
liver dysfunction, respectively190-191. Furthermore, autophagy plays a vital role during 
the early stages of mammalian development192,193 and has been suggested to act as 
a tumor suppressive mechanism194.  
The involvement of autophagy in combating infections during innate immune 
responses has been repeatedly reported. Bacteria and viruses that reside in the 
cytosol or inside the phagosomes can be targeted for autophagosomal sequestration 
and subsequent degradation by lysosomal hydrolyses. In that way autophagy can 
contribute to the successful eradication of intracellular pathogens170, 195-196. 
Interestingly, some pathogens have evolutionary specializations which enable them 
to either escape from autophagic degradation or to use autophagosomal “niche” for 
replication in the host cells197,198. Thus, subversion of autophagic machinery may be 
another immune evasion mechanism of pathogens. Additionally, autophagy has an 
indispensable role in the survival and proliferation of peripheral T cells199 and 
development of B cells200, though the underlying function of autophagy in these 
processes remains to be resolved. 
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1.3.3    Macroautophagy and antigen presentation  
The first experimental evidence that intuitively implicated autophagy in endogenous 
antigen loading came from already mentioned MHC class II ligandome analyses of B 
cell lines141.  The identified MHC class II epitopes derived from intracellular self were 
peptides drawn from the nuclear and intracellular proteins with a long half-life, 
namely the known autophagy substrates. In the same line, Stevanovic and 
colleagues identified two epitopes derived from autophagy related protein LC3 
among naturally occurring MHC class II bound peptides of Epstein Barr virus (EBV) 
transformed human B cell lines, which implied that the autophagic machinery can 
gain access to MIIC of APC. Furthermore, authors monitored changes in the 
displayed MHCII/p repertoire upon induction of autophagy and were able to show 
that the presentation of intracellular and organellar proteins is selectively enhanced 
when autophagy is up-regulated, while the presentation of membrane bound or 
extracellular proteins does not show any dependence on autophagic activity of the 
cell142. Moreover, a consensus has emerged in the field of antigen processing that 
the MIIC represents late endosomes/lysosomes equipped with the molecular 
machinery for antigen loading.  As already described, during the maturation of 
autophagosomes, fusion with late endosomes is taking place which results in the 
formation of amphisomes. Electron microscopy studies revealed that the 
morphological appearance of amphisomes is multilamelar and multivesicular, the 
characteirsitcs that perfectly match ultrastructural appearance of MIIC in the cell117, 
163, 164. Thus, one can hypothesize that in APC these two vesicular compartments 
intersect which results in the delivery of autophagic cargo to the MHC class II loading 
machinery. Recently, the laboratory of Chirstian Münz documented that the 
postulated cross talk between autophagy and MIIC indeed takes place in both 
professional and non-professional APC, such as monocyte- derived immature and 
mature DC, B cells and interferon γ- treated human epithelial cell lines. By taking 
advantage of fluorescently labeled LC3 protein, the authors were able to visualize 
and quantify the fusion events between autophagosomes and HLA-DM rich vesicles 
of APC, and they recognized that a substantial cross talk between the two pathways 
constitutively takes place. The immunofluorescence analyses were further supported 
by ultrastructural electron microscopy studies which have convincingly shown the 
intersection of autophagosomes and MHC class II loading machinery201.  
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The first evidence that directly implicated autophagy as a functionally significant 
pathway for MHC class II antigen loading came from studies that relied on 
pharmacological inhibition of the process. Brazil et al. reported that inhibition of 
autophagy in macrophages and B cells diminishes the presentation of endogenously 
expressed complement C5 protein to CD4 T cells202. The list of endogenous antigens 
whose MHC class II presentation is dependent on autophagy grew in the years that 
followed, and now includes tumor antigens, model antigen and viral antigens203-206. 
These early studies relied on the use of chemical inhibitors of autophagy, most 
commonly an inhibitor of the class III PI3K complex which is essential in initiation 
phases of autophagosome formation, 3- methyladenine (3-MA). However, the effect 
of the drug is not exclusively autophagy specific, as it has some effects on 
endocytosis and lysosomal acidification as well, hence it may affect other catabolic 
pathways beside autophagy207. 
By taking advantage of small interfering RNA technology (siRNA) , Paludan et al. has 
been able to show that genetic interference with autophagy  results in diminished 
presentation of nuclear antigen1 of EBV (EBNA1) to CD4 T cell clones in EBV 
transformed B cell lines206. This seminal work for the first time recognized autophagy 
dependent MHC class II presentation at the physiological expression level of 
antigens. Furthermore, the same group went on to show that autophagy can 
specifically enhance the CD4 T cell responses, as targeting of influenza matrix 
protein 1 (MP1) to autophagosomes enhanced stimulation of CD4, but not CD8 MP1-
specific T cell clones 201.   
Overall, in above discussed studies the convincing evidence that autophagy can 
intersect with MIIC in APC and feed the enwrapped cytosolic cargo to MHC class II 
loading system has been presented. However, the in vivo evidence for the 
involvement of autophagy in antigen presentation during T cell development and 
adaptive immune responses is still missing. 
 
 
 
 
INTRODUCTION                                  
34 
 
1.4   Aim of the thesis 
MHC class II antigen loading pathways in thymic epithelium remain poorly defined49. 
Strikingly, analyses of GFP-LC3 autophagy reporter mice have identified the thymus 
as a rather unique site of starvation independent autophagy161. The emerging 
evidence for the existence of endogenous MHC class II antigen loading pathways in 
different subsets of human and murine APC152,201,208 and the outstanding observation 
that autophagy is constitutively active in the thymus irrespective of nutrient conditions 
encouraged us to hypothesize that TEC have subverted this ancient catabolic 
process for the generation of MHC class II ligands from  intracellular proteins.  
At the moment when this study has been initiated a good TEC-specific Cre 
transgenic mouse line has not been available, therefore we could not take advantage 
of Cre/LoxP technology and conditional knock out studies to specifically evaluate the 
role of autophagy in thymic epithelium. To circumvent the problem of neonatal 
lethality of autophagy deficient animals189, we took advantage of the embryonic 
thymus transplantations. This approach allowed us to create a “full conditional Atg5 
knock out” in thymic epithelium and to check for the role of macroautophagy in the T 
cell repertoire selection and tolerance induction.  We planned to assess the efficacy 
of positive selection by transplanting Atg5-/- E15 thymi under the kidney capsule of a 
large panel of TCR transgenic mouse strains and to check for the tolerogenic 
potential of Atg5-/- thymic epithelium by generating chimeric nu/nu thymus Atg5-/- animals.  
 
 
 
 
LETTERS
Autophagy in thymic epithelium shapes the T-cell
repertoire and is essential for tolerance
Jelena Nedjic1{, Martin Aichinger1{, Jan Emmerich1{, Noboru Mizushima2 & Ludger Klein1,3
Recognition of self-antigen-derived epitopes presented by major
histocompatibility complex class II (MHC II)molecules on thymic
epithelial cells (TECs) is critical for the generation of a functional
and self-tolerant CD4 T-cell repertoire. Whereas haematopoietic
antigen-presenting cells generateMHC-II–peptide complexes pre-
dominantly through the processing of endocytosed polypeptides1,
it remains unknown if and how TECs use unconventional path-
ways of antigen presentation. Here we address the role of macro-
autophagy, a process that has recently been shown to allow for
endogenousMHC II loading2–6, in T-cell repertoire selection in the
mouse thymus. In contrast to most other tissues, TECs had a high
constitutive level of autophagy. Genetic interference with auto-
phagy specifically in TECs led to altered selection of certain
MHC-II-restricted T-cell specificities and resulted in severe colitis
and multi-organ inflammation. Our findings indicate that autop-
hagy focuses the MHC-II–peptide repertoire of TECs on their
intracellular milieu, which notably comprises a wide array of
otherwise strictly ‘tissue-specific’ self antigens7,8. In doing so, it
contributes to T-cell selection and is essential for the generation of
a self-tolerant T-cell repertoire.
Thymic epithelial cells (TECs) are the only non-haematopoietic cell
types that constitutively express MHC II. Cortical TECs (cTECs)
have predominantly been implicated in positive selection of thymo-
cytes carrying self-MHC-restricted T-cell receptors (TCRs)9, whereas
medullary TECs (mTECs) fulfil a non-redundant role in tolerance
induction by ‘promiscuously’ expressing otherwise tissue-restricted
antigens (TRAs)7,8. Notably, tolerance induction towards mTEC-
derived antigens can operate through direct antigen recognition on
mTECs10 or by cross-presentation by thymic dendritic cells11.
MHC-II–peptide ligands are primarily generated through proces-
sing of exogenous proteins1. TECs, however, show a remarkably poor
efficacy in capturing and processing extracellular antigens12, suggest-
ing alternative pathways of MHC II loading. Candidate routes
through which endogenous loading of MHC II molecules may be
achieved are a TAP-dependent pathway13, chaperone-mediated
autophagy14 and macroautophagy2–6.
Macroautophagy is a bulk protein degradation process that is
upregulated to sustain metabolic fitness during food deprivation15.
Autophagosomes fuse with lysosomes for degradation of their cargo,
and it is conceivable that at this point an intersection with the
MHC II pathway occurs2. Because the thymus has been identified
as a site of unusual starvation-independent autophagic activity16,
we hypothesized that this phenomenon may facilitate endogenous
MHC II loading in TECs and thus contribute to positive selection
and/or tolerance induction.
Using green fluorescent protein (GFP)–LC3 autophagy reporter
mice16 (Supplementary Fig. 1a), we confirmed that the thymus had
robust, starvation-independent autophagic activity (Fig. 1a). In con-
trast, in many other tissues—for example, muscle—detectable auto-
phagy is induced only upon starvation (Fig. 1a and Supplementary
Fig. 1b). Absence of punctae in thymi of reporter mice with a targeted
disruption of Atg5 (autophagy-related gene 5)17,18, an essential com-
ponent of autophagosome formation, indicated that these structures
were not unspecific aggregates (Supplementary Fig. 1c).
When purified thymic stromal cells were analysed (Fig. 1b), the
highest frequency (68.56 2.9%) of autophagy-positive cells ($5
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Figure 1 | Constitutive autophagy in TECs. a, Sections of the thymus and
muscle of fed and starved GFP–LC3 mice were stained with anti-GFP Alexa
488 antibody (green) and 4,6-diamidino-2-phenylindole (DAPI; blue).
Images are representative of n5 6. b, Thymic stromal cells from GFP–LC3
mice were fixed onto glass slides and stained with anti-GFP Alexa 488 and
DAPI. Typical autophagy-positive cTECs and mTEChi are shown. The
average frequencies6 s.d. of cTECs and mTEChi scoring autophagy positive
(that is, $5 autophagosomes) in two independent preparations are
indicated. Less than 1% of dendritic cells (DCs) and mTEClo were positive.
c, Relative distribution of the number of autophagosomes in autophagy-
positive cTECs and mTEChi; a.u., arbitrary units.
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autophagosomes) was found among cTECs. In mTEC subsets19,20,
10.16 2.7% of mature MHC IIhi CD80hi mTECs (mTEChi) scored
positive, whereas autophagy was negligible among immature
MHC IIlo CD80lo mTECs (mTEClo), demonstrating a co-segregation
of autophagy with ‘promiscuous’ antigen expression21. The number
of autophagosomes in positive cells was scattered around maxima of
about 35 or 20 in cTECs or the mTEChi subset, respectively (Fig. 1c).
Although autophagy has been implicated in developmental pro-
cesses15,22, Atg5–/– mice are born at Mendelian ratios without evident
developmental abnormalities17. However, neonatal lethality of
Atg5–/– mice, at least in part caused by a perinatal metabolic crisis,
precluded a direct assessment of T-cell selection and tolerance in this
system. To assess the capacity of Atg5–/– thymi to support T-cell
development beyond the perinatal phase, we transplanted embryonic
Atg5–/– thymi under the renal capsule of normal adult recipients.
When analysed after 6 to 8weeks, Atg5–/– thymi were significantly
smaller than wild-type controls (Fig. 2a).
Several observations suggested that the reduced cellularity of
Atg5–/– grafts was not caused by aberrant differentiation of the epi-
thelial compartment. Thus, Atg5–/– grafts were properly compart-
mentalized into cortical and medullary areas (Fig. 2b) and
contained cTECs and mTECs at normal frequencies
(Supplementary Fig. 2). Expression of MHC I and II on Atg5–/– epi-
thelial cells was essentially normal; however, a slight decrease in
MHC II density was observed on cTECs (Fig. 2c). Atg5–/– mTECs
showed the typical biphasic MHC II expression indicative of normal
segregation into mTEClo and mTEChi subsets, and promiscuous
antigen expression was intact (Fig. 2d).
Next we considered whether the reduced cellularity of Atg5–/–
grafts may have resulted from perturbed T-cell development.
Ratios of thymocyte subsets including CD251 Foxp31 regulatory T
cells were normal in H-2d Atg5–/– (Fig. 3a) or H-2b Atg5–/– thymi
(Supplementary Fig. 3a). TCR-a or TCR-b V-region use by CD4
single-positive (SP) thymocytes was also normal (Supplementary
Fig. 3b, c), indicating that Atg5–/– deficiency in TECs was compatible
with development of a polyclonal T-cell repertoire containing the
main T-cell lineages.
Positive selection is remarkably flexible regarding the require-
ments for the composition of MHC–peptide (MHCp) ligands on
cTECs, as exemplified by the efficient selection of polyclonal CD4
T cells in mice expressing a markedly reduced spectrum of MHCp
complexes23,24. If autophagy were to contribute to the generation of
MHC II ligands on TECs, its absence would be expected to have
rather subtle consequences. Two predictions followed from these
considerations. First, selection of particular monoclonal MHC-II-
restricted TCR specificities should be affected in Atg5–/– thymi.
Second, if the reduced cellularity of Atg5–/– thymi was caused by
altered T-cell selection, a ‘permissive’ monoclonal TCR specificity
should rescue the organ size.We tested these predictions by analysing
the selection of several MHC-II-restricted transgenic TCRs (that is,
TCR-HA restricted to I-Ed, AND restricted to I-Ek, DO11.10
restricted to I-Ad, and DEP and SEP restricted to I-Ab). In Atg5–/–
H-2d lobes grafted into TCR-HA transgenic mice, both the frequency
of CD4 SP cells expressing the TCR-HA receptor and the cellularity of
lobes were significantly reduced as compared to controls (Fig. 3b).
Similarly, Atg5–/– H-2b lobes grafted into SEP TCR transgenic hosts
had reduced cellularity, and the decreased frequency of CD4 SP cells
together with an increased expression of endogenous TCR-a chains
indicated that there was selective pressure against this TCR
(Supplementary Fig. 4). In contrast, the AND TCR seemed to be
selected as efficiently in the Atg5–/– to AND grafts as in the wild-type
to AND controls; this finding coincided with equal cellularities
(Fig. 3c). For the Atg5–/– to DEP (Supplementary Fig. 5) and the
Atg5–/– to DO11.10 (Supplementary Fig. 6) transplants, we likewise
observed efficient positive selection of the respective TCR and rescue
of thymic cellularities. Of note, the frequency of clonotype-positive
CD4 SP cells was significantly increased in the Atg5–/– to DO11.10
lobes, indicating that Atg5 deficiency could also be beneficial for the
selection of particular specificities. Transplantation of Atg5–/– lobes
into mixed (DO11.10 Rag2–/–/TCR-HA Rag2–/–) bone marrow chi-
maeras accentuated the opposing consequences of epithelial Atg5
deficiency for these TCRs (Supplementary Fig. 6d). In contrast to
these observations with MHC-II-restricted TCRs, selection of three
MHC-I-restricted transgenic TCRs (P14 restricted to H-2Db, OT-I
restricted to H-2Kb and HY restricted to H-2Db) in Atg5–/– or wild-
type lobes was indistinguishable, both with respect to expression of
the transgenic TCR chains and thymic cellularity (Fig. 3d and
Supplementary Fig. 7; see also Supplementary Table 1 for a sum-
mary). Taken together, these findings were consistent with autop-
hagy in TECs specifically shaping the MHC-II-restricted T-cell
repertoire, probably through the generation of particular MHC-II–
peptide ligands. This underscores the notion that distinct pathways
of antigen presentation in TECsmay be essential for the generation of
the ‘normal’ T-cell repertoire25,26.
Evidence that autophagy can indeed mould the composition of
MHC II ligands was recently obtained bymass spectrometric analysis
of MHC-II-bound peptides of B-lymphoblastoid cell lines in the
presence or absence of autophagy6. Quantitative considerations ren-
dered such a global assessment of the ‘MHC ligandome’ impossible
for limited numbers of ex vivo isolated TECs. To visualize whether a
particular MHC-class-II-bound peptide on cTECs was affected by
genetic interference with autophagy, we used a monoclonal antibody
(Y-Ae) that recognizes I-Ab when occupied by a I-Ea-derived pep-
tide27. The I-Ea52-68–I-A
b complex is abundant on haematopoietic
antigen-presenting cells (,10% of all I-Ab–peptide complexes)27,
probably as a result of co-sorting of I-E and I-A molecules.
Notably, however, this complex is comparatively underrepresented
on cTECs, and it was hypothesized that this was due to competition
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Figure 2 | Epithelial differentiation in the absence of Atg5. a, Thymi from
wild-type (WT) or Atg5–/– embryos were transplanted under the kidney
capsule of wild-type recipients and analysed 6weeks later. The average
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for I-Ab binding by peptides that may be expressed and/or processed
in a cTEC-specific manner. When we analysed cTECs from F1
(BALB/c3C57BL/6) Atg5–/– lobes, we found an increased abund-
ance of the I-Ea52–68 –I-A
b complex as compared to wild-type con-
trols, whereas total MHC II levels showed an inverse behaviour
(Fig. 3e, compare with Fig. 2c). These findings provided direct evid-
ence that Atg5 deficiency causes a quantitative shift in the MHC II
ligandome of cTECs. We propose that in Atg5–/– cTECs, a set of
epitopes that rely on autophagy for endogenous MHC II loading
may not compete with the Ea peptide, which itself may easily gain
access to MHC II by other pathways.
To address whether the T-cell repertoire selected by Atg5–/– TECs
was self-tolerant, Atg5–/– or Atg51/1 thymi were grafted under the
kidney capsule of athymic mice (designated nu/nuAtg5–/– or nu/nuWT,
respectively). The peripheral repertoire of CD4 T cells was similar
with respect to Va and Vb use in both sets of chimaeras
(Supplementary Fig. 8). However, the frequency of CD4 T cells with
an activated phenotype (CD62Llo and CD691) was significantly
increased in the nu/nuAtg5–/– chimaeras (Fig. 4a). Between 4 and
6weeks after grafting, wasting began in nu/nuAtg5–/– but not nu/
nuWT chimaeras, and most of the nu/nuAtg5–/– chimaeras had to be
killed between 8 to 16 weeks after grafting (Fig. 4b). Recipients of
Atg5–/– thymi had patches of flaky skin, and inspection of internal
organs showed a massively enlarged colon, atrophy of the uterus,
complete absence of fat pads and inmany cases enlarged lymph nodes
(Fig. 4c). Histological examination demonstrated inflammatory
infiltrates in the colon, liver, lung, uterus and Harderian gland
(Fig. 4d and Supplementary Table 2). Chimaeras generated with
5 days deoxyguanosine treatment of embryonic lobes or by trans-
plantation immediately after preparation yielded essentially identical
outcomes, excluding organ-culture-related epithelial tissue damage
or carry-over of Atg5–/– haematopoietic cells as critical factors for
disease development. The latter point was bolstered by the fact that
Atg5–/– to wild-type fetal liver chimaeras did not show any signs of
autoimmunity (Supplementary Fig. 9; ref. 28).
Adoptive transfer of 13 107 purified CD901 T cells from nu/
nuAtg5–/– chimaeras into nu/nu recipients recapitulated essentially
all aspects of autoimmunity as observed in donor chimaeras
(Supplementary Fig. 10). When transferred separately, CD41 T cells
from nu/nuAtg5–/– chimaeras elicited autoimmune symptoms more
efficiently than CD81T cells, in line withAtg5–/– deficiency in thymic
epithelium primarily perturbing the selection of the CD4 T-cell rep-
ertoire (data not shown).
Taken together, we propose that perturbations in both positive
and negative selection caused by Atg5 deficiency in TECs may syner-
gize to fuel autoimmunity. First, alterations in the composition of
MHCp ligands on cTECs may affect positive selection, potentially
creating a mildly lymphopenic environment that might foster auto-
immunity. Second, impaired presentation of TRAs by mTECs may
allow for exit into the periphery of autoreactive thymocytes that
would normally be deleted or deviated into the regulatory T cell
lineage.
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Figure 3 | Atg5 deficiency modulates selection of MHC-II-restricted TCR
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and n$ 2 (HY). e, Thymi from wild-type or (BALB/c3C57BL/6)F1 Atg5
–/–
embryos were transplanted into (BALB/c3C57BL/6)F1 recipients. Six
weeks after grafting, expression of the I-Ea52–68–I-A
b complex on cTECs was
analysed using the monoclonal antibody Y-Ae. Atg5–/– cTECs are shown in
red; wild-type cTECs are shown in blue. Control stainings are shown in
orange (Atg5–/–) and green (wild type). Data are representative of two
independent experiments.
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The organ selectivity of the autoimmune manifestations observed
here remains to be explained. Of note, theHarderian gland itself has a
substantial level of constitutive autophagy (Supplementary Fig. 11).
Thus, autophagy-dependent epitope display in the periphery, if not
counterbalanced by an analogous tolerogenic mechanism in the thy-
mus, may be critical for immune-mediated tissue destruction. Along
these lines, the human ATG16L1 gene was recently identified as a
susceptibility locus for Crohn’s disease29,30. Our data offer an
explanation for the association of an autophagy-related gene with
breakdown of intestinal immune homeostasis.
METHODS SUMMARY
Animals. All transgenic mouse strains have been described elsewhere. Animal
protocols were approved by local authorities.
Antibodies and flow cytometry. Flow cytometry was performed according to
standard procedures. See full Methods for antibodies.
GFP–LC3 analyses. Before analyses, mice were anaesthetized and perfused
through the left ventricle with 4% paraformaldehyde. Organs were collected
and fixed with sucrose. Tissue samples were embedded in optimal cutting tem-
perature (OCT)medium and sectioned at 5 mmbefore stainingwith an anti-GFP
antibody. For quantification, purified thymic stromal cells were obtained from
enzymatically digested thymi by a combination of density fractionation and
FACS sorting. Stromal cells were fixed onto slides and processed for staining
with an anti-GFP antibody.
Thymus transplantation. Embryonic thymi were transplanted under the kidney
capsule of female animals.Atg5–/– embryos andAtg51/1 (wild-type) controlswithin
individual experiments were obtained from the same Atg51/– pregnant female.
Histopathology. Organs were immersion-fixed and embedded in paraffin
blocks. Sections were stained with haematoxylin and eosin and automatically
scanned using the Zeiss MIRAX SCAN system.
Statistical analyses. All statistical analyses were performed using the two-tailed
Student’s t-test with unequal variance.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Animals. Atg5–/– and GFP–LC3mice have been described previously17,16. BALB/
cnu/nu animals were purchased from Taconic Farms. The AND TCR transgenic
and B10.A animals were obtained from Jackson Laboratories. The TCR-HA,
DO11.10, SEP and DEP TCR transgenic animals were described elsewhere31,32.
All mice were bred andmaintained in individually ventilated cages in the animal
facility of the Research Institute of Molecular Pathology under specific patho-
gen-free conditions. All animal studies were approved by local authorities
(MA58) and were performed according to Austrian regulations.
Antibodies and flow cytometry. Biotin-conjugated monoclonal antibody Y-Ae
was a gift from B. Kyewski. The following monoclonal antibodies were used:
biotin-conjugated antibody to CD11c (HL3), CD62L (MEL14), CD80 (16-
10A1), Vb3 (KJ25) and Vb14 (14-2); fluorescein isothiocyanate (FITC)-conju-
gated antibody to CD62L (MEL14), CD90.1 (HIS51), H-2Kb (AF6-88.5), Va8.3
(KT50), Vb3 (KJ25), Vb4 (KT4), Vb5.1,5.2 (MR9-4), Vb6 (RR4-7), Vb8.1/2
(MR5-2), Vb8.3 (1B3.3) and Vb13 (MR12-3); phycoerythrin-conjugated anti-
body to CD69 (H1.2F3), Ly51 (BP-1), Va2 (B20.1), Va11.1,11.2 (RR8-1), Vb2
(B20.6), Vb7 (TR310), Vb8.3 (1B3.3) and Vb10 (B21.5); CyChrome-conjugated
antibody to CD8 (53-6.7) and CD45 (30-F11); phycoerythrin-Cy7 conjugated
antibody to CD25 (PC61); allophycocyanin-conjugated antibody to CD4 (RM4-
5) and CD8 (52-6.7); allophycocyanin-indotricarbocyanin-conjugated antibody
to CD4 (GK1.5); and phycoerythin-Cy7-conjugated streptavidin and FITC-con-
jugated streptavidin (Becton Dickinson). Phycoerythrin-conjugated monoclo-
nal antibody to TCR-HYa (T3.70) was purchased from eBiosciences. Ulex
europaeus agglutinin (UEA-1) was purchased from Sigma Aldrich and conju-
gated to Alexa 647 in our laboratory. Monoclonal antibodies specific for TCR-
HA (6.5), DO11.10 (KJ1-26), EpCAM (G8.8), Vb8 (F23.1), pan-MHC class II
(P7.7) and CD4 (GK1.5) were purified from hybridoma supernatants and con-
jugated to biotin, Alexa Fluor 488 or Alexa Fluor 647 in our laboratory. Surface
staining was performed according to standard procedures at a density of 13 106
to 33 106 cells per 50ml. FoxP3 intracellular staining was carried out according
to the manufacturer’s recommendations with phycoerythrin- or allophycocya-
nin-conjugatedmonoclonal antibodies tomouse FoxP3 (FJK-16s, eBiosciences).
A FACSCanto (Becton Dickinson) with FACSDiva software (Becton Dickinson)
was used for data acquisition and the Flow Jo software was used for data analysis.
Immunofluorescence. Frozen sections (5mm) were fixed in cold acetone, and
then washed and blocked for 30min with 10% (v/v) FCS in PBS. Sections were
permeabilized in 0.1% (v/v) Tween in PBS for 10min, and stained overnight at
4 uC with biotinylated anti-keratin 8 antibody (TROMA-1, Developmental
Studies Hybridoma Bank). Sections were incubated with secondary antibody
for 90min at room temperature and, after washing three times for 15min each
in 0.1% (v/v) Tween in PBS, were blockedwith anti-rat serum (Jackson Immuno
Research Laboratories) for 30min at room temperature. After washing, sections
were incubated with anti-keratin 5 antibody (Covance) for 2 h at room temper-
ature. Secondary reagents were streptavidin-Cy3 (Jackson Immuno Research
Laboratories) and Alexa-Fluor-488-conjugated anti-rabbit antibody
(Molecular Probes). Nuclei were counterstained with ProLong Gold antifade
reagent with DAPI (Molecular Probes). Samples were analysed with an inverted
confocal LSM 510 laser scanning confocal microscope (Zeiss).
GFP–LC3 analyses. GFP–LC3 mice and wild-type controls were maintained on
a normal diet or kept without food for 48 h before analyses, with free access to
drinking water. Before analyses, mice were anaesthetized and perfused through
the left ventricle with 4% paraformaldehyde in PBS. Organs were collected and
further fixed with the same fixative for 4 h, followed by treatment with 15%
sucrose in PBS for 4 h at room temperature and then with 30% sucrose solution
overnight at 4 uC. Tissue samples were embedded in OCT (Sakura Finetek
Europe B.V.) and stored at 270 uC. The samples were sectioned (5mm), and
stained with Alexa-Fluor-488-conjugated anti-GFP antibody (Molecular
Probes) overnight at 4 uC. Samples were mounted using ProLong Gold antifade
reagent with DAPI.
Quantification of autophagic activity in thymic stromal cells. Thymi from
two-week-old GFP–LC3 mice were cut into small pieces and digested at 37 uC
in IMDM containing 0.2mgml21 collagenase (Roche), 0.2mgml21 dispase I
(Roche), 2% FCS, 25mMHEPES (pH7.2) and 25 mgml21 DNase I, followed by
incubation in 5mM EDTA for 5min. Cells were washed and resuspended in
Percoll (GE Healthcare), followed by a layer of Percoll and PBS as the upper
phase. Gradients were spun for 30min at 1,350g in the cold, and low density cells
were collected from the upper interface, washed and then stained for FACS
sorting. Stromal cells were sorted according to CD45, Ly51, EpCAM, CD80
and CD11c expression (cTECs: CD452Ly511EpCAM1; mTEClo:
CD452Ly512EpCAM1CD80lo; mTEChi: CD452Ly512EpCAM1CD80hi; dend-
ritic cells: CD451CD11c1) and fixed on to poly-L-lysine-coated slides (Sigma
Aldrich) with ice cold acetone. Cells were permeabilized in 0.1% (v/v) Tween in
PBS for 10min, and blocked with 10% (v/v) FCS in PBS for 30min at room
temperature. Cells were incubated overnight at 4 uC with Alexa-Fluor-488-con-
jugated anti-GFP antibody and mounted with ProLong Gold antifade reagent
with DAPI. A total of 1,000 dendritic cells, 1,845 cTECs, 1,232 mTEChi and 245
mTEClo have been analysed for determination of the percentage of autophagy-
positive cells. Cells with more than five autophagosomes (that is, GFP-positive
punctae between 0.5 and 1.5mm in diameter) were scored as positive. For quan-
tification of the number of autophagosomes per cell, a total of 81 autophagy-
positive cTECs and 51 autophagy positive mTEChi have been recorded and
analysed. Cells were analysed with an inverted confocal LSM510 Zeiss micro-
scope by taking Z stacks of 0.5mm thickness and subsequently the number of
autophagosomes in the whole cell was determined.
Purification and adoptive transfer of T cells. Pooled cell suspensions of spleen
and lymph nodes (mesenteric, inguinal, axillary, brachial, superficial cervical,
deep cervical and lumbar) from nu/nuAtg52/2 and nu/nuWT chimaeras were
subjected to erythrocyte lysis. Cells were then incubated with Fc-receptor-block-
ing antibody (2.4G2) andwere stainedwith biotin-anti-CD90.2 (30-H-12). After
incubation with streptavidin microbeads (Miltenyi Biotec), CD901 cells were
positively selected onmidi-MACS columns. 13 107CD901 cells were injected in
a volume of 200ml in PBS into the lateral tail veins of BALB/cnu/nu animals.
Animals were analysed 6–12weeks after transfer.
Thymus transplantation. Embryonic thymi (E15; with or without deoxyguano-
sine treatment) were transplanted under the kidney capsule of female animals.
Atg5–/– embryos andAtg51/1 (wild type) controls in individual experiments were
obtained from the same Atg51/– pregnant female after mating to a Atg51/– male.
Deoxyguanosine treatment. E15 thymic lobes were placed on 0.45mm mem-
brane filters (Milipore) supported by Gelfoam (Pharmacia&Upjohn) and were
incubated for 5 days with 10% (v/v) IMDM supplemented with 1.35mM
2-deoxyguanosine before transplantation.
Bone marrow chimaeras. For mixed bone marrow chimaeras, T-cell-depleted
TCR-HA Rag2–/– CD45.11/1 and DO11.10 Rag2–/– CD45.11/– bone marrow
were mixed at a ratio of 1:1 and a total of 13 107 cells were injected into the
lateral tail vein of irradiated BALB/c recipients (23 450 rad). Animals were
transplanted with Atg5–/– or Atg51/1 (wild-type) lobes 4 weeks after bone mar-
row reconstitution. Grafts were analysed 6weeks after transplantation.
Fetal liver chimaeras. Fetal livers were harvested from E15 embryos. A total of
5.53 106 fetal liver cells were injected into the lateral tail veins of irradiated
(23 550 rad) CD45.1 C57BL/6 recipients. Chimaeras were analysed 12weeks
after reconstitution.
Semiquantitative RT–PCR.mTECs were isolated from 4–5 transplanted thymi
as described above and total RNAwas isolated using the high pure RNA isolation
kit (Roche). RNA was reverse transcribed using the iScript RT kit (Biorad). PCR
reactions were carried out in a final volume of 25 ml using the Advantage 2
polymerase mix (Clontech) and Advantage 2 PCR buffer SA (Clontech) accord-
ing to the manufacturers’ recommendations. dNTPs (Fermentas) were used at a
final concentration of 200mM and primers were used each at 400 nM final
concentration.
Primers were Aire forward: 59-GAGTCACAGCACCTTCCTCTT-39 (438 base
pairs (bp)); Aire reverse: 59-GGGACAGCCGTCACAACA-39 (438 bp); Spt1 for-
ward: 59-TGAAACTCAGGCAGATAG-39 (383 bp); Spt1 reverse: 59-GAGGGAG
AATAGTCAGGAT-39 (383 bp); Tff3 forward: 59-CTGGCTAATGCTGTTGG
TG-39 (377 bp); Tff3 reverse: 59-TGTTGGCTGTGAGGTCTTT-39 (377 bp);
Csn2 forward: 59-TCATCCTCGCCTGCCTTGT-39 (401 bp); Csn2 reverse: 59-
GCGGAGCACAGTTTCAGAGTT-39 (401 bp); Actb forward: 59-GGTGGG
AATGGGTCAGA-39 (380 bp); Actb reverse: 59-GAGCATAGCCCTCGTAG
AT-39 (380 bp).
All amplicons span at least one intron. Cycling conditions were as follows:
94 uC for 3min; 331 (Actb), 334 (Aire), 336 (Csn2/Tff3), 338 (Spt1) 94uC for
20 s, 56 uC for 30 s, 72 uC for 30 s; 72 uC for 5min. Samples were run on a 1.5%
(w/v) agarose and ethidium bromide gel in TAE buffer.
Histopathology.Organswere collected fromdonor animals and immersion-fixed
with either 4% paraformaldehyde overnight at 4 uC or in an IHC zinc fixative
(Becton Dickinson) for 48h at room temperature. Samples were embedded in
paraffin blocks. Sections (3–5mmthick)were stainedwithhaematoxylin and eosin
and automatically scanned using the Zeiss MIRAX SCAN system. Subsequently,
sections were analysed ‘blind’ using the Zeiss MIRAX VIEWER software.
Statistical analyses. All statistical analyses were performed using the two tailed
Student’s t-test with unequal variance.
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Figure S1. Constitutive autophagy is low to undetectable in a large panel of 
organs. a, Schematic of how GFP-LC3 fusion proteins are incorporated into 
autophagosomes and can be used to monitor autophagic activity. b, Tissue-
sections of organs from normally fed GFP-LC3 mice were assessed for autophagic 
activity by staining with anti-GFP Alexa 488 antibody (green) and DAPI (blue). 
Note that the diffuse cytoplasmic green fluorescence in all organs is caused by 
ubiquitous expression of GFP-LC3, whereas GFP+ autophagosomes, i.e. punc-
tate structures of 0.5-1.5 μm in diameter, are largely absent. Data are representa-
tive of n ≥ 3. c, Thymus sections (E15.5) of GFP-LC3 mice on Atg5+/+ (WT) or 
Atg5–/– background were assessed for the presence of GFP+ puncta as 
described above. Genetic interference with the enzymatic cascade leading to 
autophagosome formation abrogates formation of green puncta, indicating that 
these structures are true autophagosomes and not unspecific aggregates.
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Figure S2. Normal ratio of mTEC and cTEC in Atg5 deficient thymic grafts. H-2k 
Atg5–/– or Atg5+/+ (WT) E15 lobes were grafted into mice expressing the I-Ak 
restricted AND T cell receptor. Note that in these experiments, we used AND TCR-
transgenic hosts rather than WT hosts in order to exclude distortions in the cTEC / 
mTEC ratio eventually caused as a secondary effect of the reduced organ size in WT 
hosts. Eight weeks after grafting, lobes were harvested and TEC-enriched cell sus-
pensions were prepared by digestion with collagenase / dispase follwed by density 
fractionation. Cells were stained with antibodies to CD45 (pan-hematopoietic), 
EpCAM (G8.8; pan-epithelial) and Ly51 (cTEC). Histograms show expression of Ly51 
on gated CD45–EpCAM+ cells (total TEC). Numbers in plots indicate the frequency 
of cTEC among total TEC.
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Figure S3. Polyclonal T cell selection by H-2b and H-2d Atg5 deficient 
thymic epithelium. Thymus lobes from Atg5+/+ (WT) or Atg5–/– E15 embryos on 
H-2b background were transplanted under the kidney capsule of H-2b WT recipi-
ents. a, FACS-analysis of T cell development in Atg5–/– → WT or Atg5+/+ (WT) → 
WT grafts. Upper dot plots show CD4 versus CD8 staining (representative of n = 
14 and n = 8, respectively), lower dot plots show expression of the regulatory T 
cell markers CD25 and Foxp3 (intracellular staining) on gated CD4 single-positive 
thymocytes (representative of n = 5 each). b,c Comparison of TCR V-region 
usage by CD4 SP cells from Atg5–/– → WT (white bars), Atg5+/+ (WT) → WT 
grafts (grey bars) and normal WT thymi on H-2d (b) or H-2b (c) background. Data 
are representative of 3 lobes analyzed individually for each genotype.
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Figure S4. Impaired selection of SEP TCR transgenic T cells by Atg5 defici-
ent thymic epithelium. Thymus lobes from Atg5+/+ (WT) or Atg5–/– E15 embryos 
on H-2b background were transplanted under the kidney capsule of H-2b SEP 
TCR-transgenic recipients (Vβ8.3 / Vα4). The dot plots show CD4 versus CD8 stai-
ning of thymocytes. Lacking a Vα4 specific staining reagent, we assessed the 
expression of endogenously rearranged α-chains as an indirect measure of the 
selection efficiency in this system. The histograms show expression of endoge-
nously rearranged TCR α-chains (Vα2 and Vα8.3) on gated CD4 SP cells. The 
frequency of cells expressing individual endogenously rearranged α-chains varied 
widely between individual Atg5–/– grafts, but consistently was substantially higher 
than in WT lobes. Data are representative of n ≥ 6.
doi: 10.1038/nature07208                                                                                                                                                SUPPLEMENTARY INFORMATION
www.nature.com/nature 4
Vα11
V
β5
.1
Atg5 –/–      DEPWT      DEP
gated CD4 SP
22.8 18.8
80.0 80.6
Supplementary Figure 5
CD8
C
D
4
Figure S5. Normal selection of DEP TCR transgenic T cells by Atg5 
deficient thymic epithelium. Thymic lobes from Atg5+/+ (WT) or Atg5–/– 
E15 embryos on H-2b background were transplanted under the kidney 
capsule of H-2b DEP TCR-transgenic recipients (Vβ5.1/ Vα11). The upper 
dot plots show CD4 versus CD8 staining of thymocytes. The lower dot plots 
show expression of the transgenic TCR V-segments on gated CD4 SP 
cells. Data are representative of n = 5 each.
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Figure S6. Enhanced selection of DO11.10 TCR transgenic T cells in the 
absence of Atg5 in TEC. Thymus lobes from Atg5+/+ (WT) or Atg5–/– E15 embryos 
on H-2d background were transplanted under the kidney capsule of DO11.10 TCR-
transgenic recipients. (n = 5 for Atg5–/– → DO11.10 and n = 9 for Atg5+/+ (WT) → 
DO11.10 grafts). a, Expression of the DO11.10 TCR on gated CD4 SP thymocytes as 
assessed by staining with the clonotypic antibody KJ1-26. Numbers indicate the 
frequency ± SD of KJ1-26+ CD4 SP cells (P = 0.008). b, Cellularity of Atg5–/– → 
DO11.10 and Atg5+/+ (WT) → DO11.10 grafts. c, Frequency of thymocyte subsets. 
Note the significantly increased frequency of CD4 SP cells (P = 0.001) at the expense 
of the DP compartment (P = 0.002) in Atg5–/– → DO11.10 grafts. d, Competitive 
development of TCR-HA and DO11.10 thymocytes in Atg5–/– or Atg5+/+ (WT) lobes. 
BALB/c mice were lethally irradiated and reconstituted with a 1 : 1 mixture of bone 
marrow cells from TCR-HA rag2–/– and DO11.10 rag2–/– mice. These chimeras then 
received grafts of Atg5–/– or Atg5+/+ (WT) lobes under the left or right kidney capsu-
le, respectively. The dot plots show expression of the two transgenic TCRs on gated 
CD4 SP thymocytes. Data are representative of three chimeras.
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Figure S7. Unaltered selection of MHC class I restricted transgenic TCRs 
by Atg5–/– TEC. Thymus lobes from Atg5+/+ (WT) or Atg5–/– E15 embryos on 
H-2b background were transplanted under the kidney capsule of (a) P14, (b) 
OT-I or (c) HY TCR-transgenic recipients. The dot plots show CD4 versus CD8 
staining of thymocytes.
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Figure S8. V-region usage by lymph node CD4+ cells from Atg5–/– → nu/nu 
or Atg5+/+ → nu/nu chimeras. Comparison of TCR V-region usage by lymph 
node CD4+ cells from Atg5–/– → nu/nu (white bars), Atg5+/+ (WT) → nu/nu grafts 
(grey bars) and normal WT (BALB/c) thymi on H-2d background as assessed by 
flow cytometric analysis eight to twelve weeks after grafting (n = 6 for each geno-
type).
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Figure S9. Atg5 deficiency in hematopoietic cells does not cause autoim-
munity. Lethally irradiated (2 x 450 rad) WT animals were reconstituted with 
Atg5–/– or Atg5+/+ (WT) fetal liver cells. These chimeras did not show any signs 
of autoimmunity twelve weeks after reconstitution. Representative histological 
sections (H&E) of colon and harderian gland are shown (n = 3 each).
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Figure S10. Adoptive transfer of purified T cells from Atg5–/– → nu/nu chime-
ras recapitulates autoimmunity. a, 1 × 107 purified CD90+ T cells from 
nu/nuAtg5–/– or nu/nuWT chimeras eight weeks after thymus grafting were adop-
tively transferred into nu/nu recipients. Depicted is the typical external appearance of 
recipients ten weeks after T cell transfer (representative of two independent experi-
ments, n = 5). b, Changes in body weight (Δ weight) were monitored up to eleven 
weeks. c, H & E staining of sections of representative organs from recipients of 
nu/nuAtg5–/– or nu/nuWT T cells.
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Figure S11. Constitutive autophagy in the Harderian gland. Tissue-sections 
of the Harderian gland of normally fed (non-starved) GFP-LC3 mice and GFP-
LC3 mice that had been deprived of food for 48 hours (starved) were stained 
with anti-GFP Alexa 488 antibody (green) and DAPI (blue) to visualize 
autophagic activity.
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Supplementary Table 1 
 
 
 
 
MHC II restricted TCR tansgenes 
 
 Restriction 
Element 
Organ 
Size 
Positive 
Selection 
TCR-HA I-Ed ↓ ↓ 
DO11.10 I-Ad = ↑ 
AND I-Ek = ↑ 
SEP I-Ab ↓ ↓ 
DEP I-Ab = = 
 
 
MHC I restricted TCR tansgenes 
 
 Restriction 
Element 
Organ 
Size 
Positive 
Selection 
P14 Db = = 
OT-I Kb = = 
HY Db = = 
 
 
Table S1. Selection of transgenic TCRs in Atg5–/– thymi as compared to WT 
controls. Positive Selection: ↑ and ↓ indicate a higher or lower frequency of 
clonotype positive CD4 or CD8 SP cells, respectively. = indicates that the 
frequency of clonotype positive SP cells was similar in Atg5–/– thymi and WT 
controls. 
Organ Size: ↓and = indicate lower or equal cellularity, respectively, of Atg5–/– 
thymi as compared to WT controls. 
doi: 10.1038/nature07208                                                                                                                                                SUPPLEMENTARY INFORMATION
www.nature.com/nature 12
 
 
 
 
 
 
 
 
Supplementary Table 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2. Infiltrates in nu/nuWT or nu/nuAtg5–/– chimeras. * indicates a mild 
infiltration without histopathological changes of the Harderian gland (as opposed 
to manifest signs of tissue destruction in nu/nuAtg5–/– chimeras). ** indicates focal 
accumulation of mononuclear cells around the Fallopian tube in the absence of 
thinning of the organ (as opposed to infiltration throughout the organ in nu/nuAtg5–
/– chimeras). 
 
 
 
 
 nu/nu WT nu/nu Atg5–/– 
Colon 0 / 16 13 / 15 
Harderian Gland 5* / 16 12 / 16 
Uterus 2** / 11 10 / 12 
Liver 4 / 16 9 / 16 
Lung 4 / 16 9 / 15 
doi: 10.1038/nature07208                                                                                                                                                SUPPLEMENTARY INFORMATION
www.nature.com/nature 13
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3.    DISCUSSION 
 
3.1   High constitutive level of autophagy in thymic epithelium 
 
For a long time autophagy has been recognized as a basic cellular response to 
starvation, with a main role in sustaining the energy status of the cell during stressful 
conditions157, 209. Typically, the basal level of autophagy is low (Supplementary Figure 
1b), but the process gets up-regulated upon food withdrawal in order to sustain 
metabolic homeostasis (“induced” autophagy) (Figure 1a-lower panel). However, 
here we presented data arguing that the process of autophagy is differentially 
regulated among several organs and cell types in mice, as basal autophagy levels as 
well as cell response to starvation treatment widely differs (Figure 1, Supplementary 
Figure 1b). These findings are in agreement with previously published studies of 
Ohsumi and colleagues161. 
 
Extensive in vivo analyses of autophagy reporter mice (GFP-LC3) have documented  
a high constitutive level of autophagy in the thymus, even under nutrient-rich 
conditions, a pattern that has been observed in only two more cell types: podocytes 
and lens epithelial cells161. Here, we identified a new cell type showing the similar 
pattern of autophagic activity, namely the subset of cells in the Harderian gland 
(Supplementary Figure 11). Interestingly, the basal level of autophagy in the thymus 
is higher in neonates than in adult thymi161. However, it remains to be answered if up-
regulation of autophagy during the neonatal period in the thymus is a result of a 
physiological starvation that happens in mammals shortly after birth when nutrient 
supply via placenta is suddenly terminated189, or if it is related to the specific 
immunological function of the organ.  
 
In order to precisely assign autophagic activity to a particular population of thymic 
stromal cells we performed a detailed quantification of autophagy on sorted cells 
(purity ≥98%). We documented that the highest autophagic activity is confined to the 
cTEC subset with ~70% of cells being autophagy positive. Autophagy positive cTEC 
contained an average of about 35 autophagosomes per cell (Figure 1c), which 
corresponds to approximately 1-2% of total cytosolic volume being engulfed in 
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autophagosomes in the steady state. In mTEClo autophagic activity has not been 
detected, while ~10% of the mTEChi population scored positive for autophagy. 
Interestingly, high autophagic activity co-segregated with a subpopulation of mTEC 
that has optimal antigen presentation capacity: high MHC class II and CD80 
expression level, and at the same time expresses a wide array of TSA48,52, 53. The 
more detailed characterization of autophagy positive mTEChi subset will be the 
subject of our future investigation. One of the most interesting tasks would be to 
verify if autophagy positive cells are indeed Aire+ mTEC. Unlike TEC, less than 1% of 
thymic DC scored positive for autophagic activity by our monitoring assay (Figure 
1b). 
 
Our data are in a good agreement with immunofluorescence analyses of thymic 
sections from paraformaldehyde perfused autophagy reporter mice. Staining with 
epithelial markers revealed co-segregation of autophagosomes with cytokeratin 
positive cells in the cortex and medulla161. Importantly, perfusion with 
paraformaldehyde prevents the artificial induction of autophagy during the 
experimental procedure which excludes the possibility that observed high numbers of 
autophagosomes in ex vivo isolated TEC is a consequence of autophagy up-
regulation during the isolation procedure of thymic epithelium.  
 
Autophagy is not commonly up-regulated in different epithelial tissues, as we have 
not observed significant autophagic activity in epithelial cells in other organs, i.e., 
skin, salivary gland, colon. Furthermore, it appears not to be a general characteristic 
of lymphoid organs, as lymph node and spleen scored negative for autophagy 
(Supplementary Figure 1b).  
 
The caveat of the autophagy monitoring system that relies on posttranslational 
modifications of LC3 protein is that it allows for visualization of autophagosomes and 
amphisomes, while the final maturation step – formation of autophagolysosomes 
cannot be observed due to degradation of luminal portion of LC3 and covalent 
decoupling of LC3 from the outer autophagolysosomal membrane210. Therefore, the 
accumulation of autophagosomes in the steady state in GFP-LC3 reporter animals 
can indicate (i) high numbers of newly forming vesicles implying high level of 
autophagy in the cell, (ii) blockage in the fusion with lysosomes which would reflect 
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accumulation of immature autophagosomes or (iii) the inhibition of lysosomal 
degradation of autophagic cargo which would lead to accumulation of late autophagic 
vacuoles. The most accurate method to monitor autophagic activity in the cell is 
immunoelectron microscopy207. The method allows for unambiguous delineation of 
autophagosomes, which are characterized by the presence of a bilayered 
membrane, and autophagolysosomes, which are defined as single membrane 
vesicles with electron dense material. Furthermore, on the basis of electron density 
of autophagolysosomes one can estimate the activity of lysosomal proteases. 
Electron microscopy of thymic epithelium has shown numerous proteolyticaly active 
autophagolysosomes in TEC161, an observation that allows us to interpret the high 
numbers of autophagosomes in TEC from GFP-LC3 reporter mice as a sign of high 
constitutive autophagic activity. 
 
There are reports stating that over-expression of LC3 protein can lead to the 
formation of nonspecific aggregates which can be falsely interpreted as newly 
forming autophagosomes211, 212. To check for this possibility, we bred GFP-LC3 mice 
on an autophagy deficient background and analyzed the formation of 
autophagosomes in neonates. In GFP-LC3 Atg5-/- mice only the diffuse cytoplasmic 
staining has been observed (Supplementary Figure 1c), confirming that green dots 
observed in thymic epithelium are indeed autophagosomes, and not unspecific 
protein aggregates. 
 
As already mentioned, there are three homologues of the yeast Atg8 protein in 
mammals: LC3, GATA16 and GABARAP. Upon induction of autophagy all 
mammalian Atg8 homologues pass through the same posttranslational modification 
steps that ultimately lead to covalent coupling of proteins to the lipids in 
autophagosomal membranes181. Histological analyses of GFP-GATA16 and GFP-
GABARAP reporter mice have also identified the thymus as a rather unique organ 
displaying high constitutive level of autophagy irrespective of nutrient supply 
(I.Tanida and E.Kominami, unpublished results). These preliminary analyses of new 
autophagy reporter mice further support the notion that high constitutive autophagy is 
a physiological characteristic of the thymic epithelium.  
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The observed pattern of autophagic activity begs the question what the role of 
autophagy in TEC is. In the following sections, I will discuss our work that strongly 
supports the hypothesis that autophagy in TEC contributes to the generation of MHC 
class II epitopes derived from intracellular proteins and in that way contributes to 
positive selection and tolerance induction of developing T cell repertoire. 
 
3.2   Autophagy deficient thymic epithelium - basic characterization 
 
As thymic epithelial cells display high constitutive autophagic activity, we reasoned 
that genetic interference with autophagy in TEC might cause alterations in basic 
cellular functions. However, a number of different parameters reflecting TEC 
organization and function are unaffected in Atg5-/- grafts. Thus, immunofluorescence 
analyses of thymic grafts documented a proper formation of cortical and medullary 
compartments (Figure 2b), and FACS analyses further confirmed that percentages of 
cTEC and mTEC in Atg5-/- transplants are similar to WT (Supplementary Figure 2). 
MTEC properly segregate into already described mTEClo and mTEChi subpopulations 
(Figure2c-lower panel). Furthermore, promiscuous expression of Aire-dependent and 
Aire-independent tissue specific antigens in mTEC (Figure 2d) as well as expression 
of MHC class I and II molecules in Atg5-/- cTEC and mTEC is intact (Figure 2c). It is, 
however, worth mentioning that we observed a slight, but reproducible, decrease in 
MHC class II expression and quite opposite slightly enhanced expression of MHC 
class I molecules on Atg5-/- cTEC. The effects of autophagy on MHC loading and 
expression will be further discussed in the following sections.  
 
Recent studies have implicated autophagy as an important intracellular protein 
quality control mechanism, as autophagy deficient hepatocytes190 and neuronal 
cells213,191 accumulate ubiquitinylated protein aggregates, which ultimately leads to 
impaired cellular function and toxicity. The molecular mechanism of such selective 
targeting of proteins for autophagic degradation is currently unknown, although 
several proteins, such as p62/SQSTM1 and Alfy, have been shown to play important 
roles in targeting ubiquitinylated aggregates for autophagosomal degradation167, 168, 
214. It has been proposed that autophagic clearance of intracellular proteins might be 
especially important in post-mitotic or slowly dividing cells as they do not have the 
luxury of diluting toxic aggregates in the course of cell growth and division. 
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Additionally, expression of aggregation prone proteins may be elevated in 
hepatocytes and neuronal cells. However, the histological inspection of thymi from 
Atg5-/- neonates revealed that TEC do not accumulate ubiquitinylated proteins and 
inclusion bodies (N.Mizushima, personal communications). Therefore it appears that 
in TEC ubiquitinylated intracellular proteins are more efficiently targeted for 
proteasomal degradation and/or proteolysis by other cytosolic proteases involved in 
processing of intracellular proteins, which in turn can compensate for a deficiency in 
autophagic clearance of protein aggregates. The similar observation has been made 
in lens epithelial cells, which like TEC, display high level of autophagy. Additionally, 
dramatic degradation of organelles and cellular remodeling occurs during the process 
of lens differentiation. However, autophagy, even though constitutively active at the 
high level, is not essential for the elimination of organelles or ubiquitinylated proteins 
during the development of lens fibers215. Hence, one can conclude that different cell 
types have adapted autophagic process to fulfill diverse physiological tasks, and that 
proteolytic dependence on the autophagy does not show the same pattern among 
tissues. 
 
Autophagy has been shown to act as either (i) a cell survival mechanism or as (ii) a 
cell death pathway (type II programmed cell death) depending on cell types and/or 
environmental conditions216,277,278. To this end we were able to show that the 
transplanted Atg5-/- grafts survive as long as WT grafts when transplanted under the 
kidney capsule of WT animals, whereby the survival time was monitored for 5 
months. A way to address the putative role of autophagy in survival of TEC would be 
the inspection of apoptotic markers in Atg5-/- thymic grafts. However, studies of 
apoptosis with ex vivo isolated TEC are very difficult because of the induction of high 
levels of Annexin V and caspase activation as a consequence of the complicated 
TEC isolation procedure. Another approach to characterize cell death rate of TEC in 
the absence of autophagy would be to perform in situ TUNNEL assay analyses and 
quantify the number of dying TEC using immunofluorescence methodology. This fine 
delineation of effects of autophagy on the physiology of TEC will be the subject of 
future investigations. 
 
Taken together, our findings suggest that the viability and development of TEC is not 
globally affected by the absence of Atg5. Interestingly, similarly to TEC, interference 
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with autophagy in DC does not impair their viability or the general antigen 
presentation capacity, i.e., MHC class I or II expression, but it is indispensable for (i) 
innate recognition of viral particles and IFNα response in plasmacytoid DC (pDC) in 
mice and (ii) it contributes to endogenous antigen loading of intracellular pathogen-
derived and model antigens in human monocyte-derived immature and mature 
DC196,201, 206.  Thus, it seems that autophagy arms professional APC to better perform 
their immunity-related functions while at the same time house-keeping roles of 
autophagy in these cell types can be substituted by other catabolic pathways.  
 
3.3      Autophagy and Positive selection 
 
3.3.1   Diversity of MHCp complexes and its role in positive selection of 
           T cells – an overview 
 
Peptides are an essential part of MHC complexes and are required for stable 
expression of both MHC class I and class II molecules. Substantial insight regarding 
the contribution of a diverse repertoire of peptides on MHC molecules expressed on 
thymic stromal cells in selecting T cells has been gained during the early 90-ies. 
Three different theories have been put forward to describe the role of MHC bound 
peptide epitopes in TCR/MHCp interactions23. In the first scenario peptides play just 
a structural role by stabilizing MHC complexes and thereby conferring a proper 
conformation for interactions with TCR. The other two theories recognize the role of 
TCR interactions with side chains of peptides bound to the MHC, but differ in respect 
to the specificity of this interaction. While one of the models implies that the 
interaction of TCR with MHC bound peptides is degenerate, i.e., one MHCp complex 
would be able to select millions of different TCR specificities, the second model 
proposes that those interactions are highly specific and further suggest that diversity 
of peptide epitopes bound to MHC molecules is essential for the selection of a 
polyclonal T cell repertoire23,217,218. 
 
The first direct experimental evidence for the role of peptides in T cell selection came 
with a wave of studies on CD8, and subsequently CD4 T cell selection. The 
elucidation of mechanisms involved in antigen processing and loading to MHC class I 
and II molecules, made it possible to genetically modulate essential players 
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responsible for the generation of a diverse repertoire of MHC bound peptides. Using 
TAP (TAP-/-) and β2-microglobulin (β2m-/-) deficient animals, several research 
laboratories set out to study the role of peptides in selection of the CD8 T cell 
repertoire89,219,220. TAP-/- and β2m-/- animals have a very low surface expression of 
MHC class I molecules due to (i) an inefficiency in peptide shuttling to the ER where 
the MHC class I peptide loading takes place (TAP-/-) or (ii) defects in MHC class I 
complex assembly caused by the lack of the light chain molecule (β2m-/-). The 
number of CD8 T cells is greatly reduced both in the thymus and periphery of those 
animals, but the respective influence of low MHC class I expression level versus 
diminished diversity of MHCI/p complexes on the selection of CD8 T cells could not 
be delineated in these in vivo settings. However, in the fetal thymic organ cultures 
(FTOC) MHC class I expression in TAP-/- or β2m-/- system can be restored upon 
exogenous adding of peptides or β2-microglobulin and peptides, respectively. 
Furthermore, in FTOC with TAP-/- or β2m-/- one can experimentally modulate the 
diversity of peptides added to the system and evaluate the contribution of peptide 
diversity to CD8 T cell selection. These experiments revealed that  polyclonal CD8 T 
cell development is more efficient on a diverse mixture of MHCI/p complexes and 
implied that a plethora of MHCI/p complexes is required for development of diverse 
repertoire of CD8 T cells221,222. Furthermore, studies on the selection of particular 
TCR specificities revealed that only peptides related to the natural antigenic peptide 
of a respective TCR can induce positive selection, while unrelated peptides are not 
able to do so223-224. These findings talk in favor of a scenario where specific 
TCR/MHCp interactions are taking place during the process of positive selection and 
outline the importance of diversity of MHC bound peptides in selection of a full, 
polyclonal T cell repertoire.  
 
It was also in the early 90-ies that several groups have generated invariant chain (Ii) 
deficient animals (Ii-/-)109,110,225. Ii-/- animals have a 5-7 fold reduced expression of 
surface MHC class II and reduced numbers of CD4 T cells in the thymus and 
peripheral lymphoid organs. Due to the impairment in MHC II antigen loading and the 
structural instability of class II complex in this system, APC in Ii-/- mouse express 
either empty MHC II molecules or MHC II molecules weakly bound to the peptide. 
Analyses of selection of particular TCR specificities on Ii-/- background has shown a 
developmental block at the DP stage of only some TCR specificities, while other TCR 
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specificities did not show any problems with positive selection in the absence of Ii, 
implying that MHCII/p diversity is essential for the selection of at least some TCRs226. 
However, as both peptide diversity and MHC II expression level in Ii-/- animals is 
severely reduced, one cannot separate the influence of decreased MHC II 
expression versus severely reduced peptide diversity on the observed phenotype. To 
circumvent this problem, the question has been addressed by generating animals 
that express a very limited repertoire of MHCII/p complexes, while the surface MHC II 
expression remains unchanged. Two mouse models have been created that fulfill 
these criteria, H-2M-/- animals and the so called “single ligand” mouse model227, 228. 
The molecular chaperone H-2M facilitates the dissociation of the CLIP peptide from 
the MHC class II peptide binding groove and subsequent loading of antigenic 
peptides. Therefore, in H-2M-/- animals the vast majority of MHC class II molecules 
are occupied with a CLIP peptide (~97%)229. In a “single ligand” model mice deficient 
for endogenous MHC II (MHC II-/-) and invariant chain (Ii-/-) transgenically express a 
class II molecule (I-Aβb) that is covalently linked to the I-Eα(52-68) peptide- AbEp. 
Consequently, in the AbEp mouse, virtually all MHC class II molecules are loaded 
with the I-Eα(52-68) peptide. Analyses of both mouse models gave essentially the same 
results. Those animals are able to support bulk CD4 T cell development, though the 
number of CD4 T cell is reduced both in the thymus and the periphery. Subsequent 
analyses of the CD4 T cell receptor diversity have documented the selection of a 
broad, polyclonal T cell repertoire with respect to TCR Vβ segment usage and 
sequence analyses of the complementary determining region-3 (CDR-3). However, 
three different TCR specificities (SMARTA, Dep and AND TCRs) have displayed a 
complete developmental block at the DP stage when selected on an H-2M-/- 
background. Results discussed above would imply a rather redundant role of 
peptides in the selection of CD4 T cells. One single MHCII/p complex would be able 
to support selection of a highly diverse, though not complete CD4 repertoire230. 
These findings are quite opposite to the findings on positive selection of CD8 T cells. 
“Single ligand” mouse models imply that positive selection of CD4 cells is a rather 
promiscuous process with regard to the specificity of peptide/TCR interactions, while 
CD8 TCR/MHCp interactions are suggested to be highly specific 224,231. 
 
Such a redundant role of peptides in selecting a broad CD4 T cell repertoire has 
been challenged by more elegant analyses of positive selection in H-2M-/- FTOC and 
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findings of Barton et al. in another “single ligand” mouse model, where similarly to 
AbEp mouse, ~95% of MHC II molecules are occupied with the I-Eα(52-68) peptide232 , 
233. By using specific monoclonal antibodies in FTOC the authors blocked the 
interactions of developing T cells with either MHCII/CLIP or MHCII/I-Eα complex. The 
only MHCII/p complexes developing T cells could react with in these FTOC are 
remaining low abundance MHCII/p complexes. Interestingly, positive selection 
worked equally efficient when the interactions with a “single ligand” have been 
blocked, but was significantly diminished if H-2M-/- FTOC were treated with a 
monoclonal antibody that is specific for MHC II/non-CLIP epitopes. Those data argue 
that the positive selection in “single ligand” mouse models actually occurs on the 
remaining minute amounts of MHCII/p complexes that contribute to the diversity of 
MHC class II ligandome and support the hypothesis that a diverse repertoire of MHC 
II bound peptides is absolutely necessary for the development of polyclonal CD4 T 
cells. 
 
3.3.2    Diversity of MHCII/p complexes and its role in positive selection of 
            CD4 T cells – role of autophagy 
 
We speculated that autophagy could be one of the alternative endogenous MHC 
class II loading pathways in TEC that shuttles intracellular proteins to MIIC. In that 
way, autophagy would contribute to the diversity of the MHCII/p repertoire of cTEC 
that is presented to developing T cells during the process of positive selection. 
Nevertheless, autophagy should have rather subtle consequences on the diversity of 
MHCII/p repertoire in comparison to “single ligand” mouse models as other antigen 
loading pathways are still operative in Atg5-/- cTEC. Therefore, one would speculate 
that the changes, if evident, in the diversity of the CD4 T cell repertoire would be 
rather subtle in autophagy deficient animals and that it would affect only particular T 
cell specificities which selection is mediated by autophagy-dependent MHC class II 
epitopes. 
 
Experiments designed to test the efficacy of positive selection on autophagy deficient 
thymic epithelium revealed that a broad repertoire of T cells is selected. Developing T 
cells properly proceed through DN, DP, CD4SP and CD8SP stages of development 
and percentages of cells falling into those categories are same as in WT (Figure 3a 
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and Supplementary Figure 3a). Furthermore, athymic, nude animals grafted with 
Atg5-/- embryonic thymi have a fully reconstituted T cell compartment in peripheral 
lymphoid organs. The selected CD4 T cell repertoire appears to be broad and 
polyclonal, as judged by unimpaired usage of a large panel of Vβ and Vα TCR 
segments both in the thymus (Supplementary Figure 3b and 3c) and periphery 
(Supplementary Figure 8).  
 
To get a closer insight into the diversity of a selected T cell repertoire we performed 
in depth analyses of Atg5-/- cTEC capacity to select different TCR specificities, by 
taking advantage of already established TCR transgenic mouse models. Those 
analyses revealed that positive selection of particular MHC class II- restricted TCRs 
is altered on Atg5-/- thymic epithelium (Supplementary Table 1). Interestingly, 
different T cell specificities display opposite outcomes of positive selection on Atg5-/- 
epithelium. While TCR-HA and Sep specific T cells show less efficient positive 
selection on Atg5-/- thymic epithelium, i.e., reduced numbers of CD4SP T cells 
expressing the transgenic TCR (TCR-HA system) and increased frequency of 
CD4SP with endogenously rearranged Vα TCR segments (Sep TCR system), (Figure 
3b and Supplementary Figure 4), positive selection of DO11.10 TCR transgenic 
animals seems to be more efficient on Atg5-/- cTEC (Supplementary Figure 6a and 
6c). The increased secondary TCRα gene rearrangements in Sep TCR transgenic 
animals may indicate that cells attempt to produce a receptor that can be more 
efficiently selected by available MHCII/p complexes and thus escape death by 
neglect. Efficacy of positive selection of AND and Dep TCR transgenic cells is 
comparable between WT and Atg5-/- epithelium (Figure 3c and Supplementary Figure 
5). Curiously, the peptide mediating positive selection of AND TCR, gp250, has been 
recently identified in in vitro system. The gp250 peptide is derived from a sortilin 
family-related multifunctional endocytic receptor protein. The protein is expressed in 
a wide array of APC, including cTEC (Allen P., unpublished data). As an endosomal 
protein, gp250 can intersect with MIIC by following conventional rules of MHC class II 
antigen loading. Thus, loading of the gp250 peptide to the MHC class II should be 
independent of autophagy. Notwithstanding the fact that respective role of gp250 
peptide in in vivo selection of AND TCR transgenic animals has not been shown, this 
finding captured our attention as AND TCR specificity has shown autophagy-
independent positive selection outcome which stands in line with the assumption that 
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the ligand mediating its selection follows the classical, endocytic antigen loading 
route. 
 
Experiments with mixed bone marrow chimeras where animals expressed only two 
TCR specificities, TCR-HA and DO11.10, recapitulated our findings from the 
analyses of positive selection in the single TCR transgenic system. In this 
“competitive” system positive selection of cells expressing DO11.10 TCR is 
enhanced on the account of reduced numbers of cells expressing TCR-HA in Atg5-/- 
epithelium (Supplementary Figure 6d). These findings imply competition among T 
cells with different specificities for selecting ligands during positive selection, which is 
in agreement with published data234. Thus, the selection of some MHC class II- 
restricted TCRs critically relies on autophagy-dependent epitopes (TCR-HA, Sep 
TCR). On the other hand, the absence of autophagy-dependent epitopes in the MHC 
class II ligandome may favor selection of TCRs that specifically recognize epitopes 
drawn from non-autophagic substrates (DO-11.10 TCR).  
 
The finding that some MHC class II- restricted TCR transgenics can be positively 
selected on autophagy deficient cTEC, while the selection of TCRs with other 
specificities is substantially affected, shows that the general ability of Atg5-/- cTEC to 
mediate positive selection of developing T cells is not impaired. As already 
mentioned, we observed a slight, but reproducible, down-regulation of MHC class II 
expression in Atg5-/- cTEC. This finding may imply that the loading of peptides to the 
MIIC is impaired in Atg5-/- cTEC, as peptide binding to the MHC class II groove is 
essential for the stabilization and expression of MHC class II molecules on the cell 
surface. In contrast to described “single ligand” mouse models233,228,229, we did not 
observe any differences in percentages of T cells at different developmental stages 
in Atg5-/- grafts transplanted to WT animals, and neither of the tested TCR transgenic 
models displayed a block in development at the DP stage. Those findings are in 
agreement with our proposed hypothesis that reduction of peptide diversity in 
autophagy deficient cTEC is not as severe as in a “single ligand” mouse models, and 
thus changes in efficacy of T cell positive selection are rather subtle. Nevertheless, 
the T cell repertoire selected on Atg5-/- thymic epithelium, though highly diverse, is 
different to the repertoire of T cells selected on WT cTEC (Graphic 6).  
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a.                                                            b.  
 
 
 
Graphic 6. The role of autophagy in positive selection of CD4 T cells. In WT mice (a.) a 
highly diverse repertoire of MHCII/self peptide complexes enables the selection of a full, 
polyclonal T cell repertoire. In autophagy deficient TEC (b) the diversity of MHCII/self peptide 
complexes is reduced which results in the selection of an altered repertoire of CD4 T cells 
(i.e., reduced frequency of TCR specificities which positive selection depends on autophagy-
dependent MHC class II epitopes-red cells, and increased frequency of TCR specificities that 
are positively selected on autophagy-independent epitopes-green and blue cells in the 
graphic). 
 
The cellularity of Atg5-/- thymic grafts transplanted to WT mice was significantly 
reduced (Figure 2a). This finding was in contrast to “single ligand” mouse models, 
where the overall thymic cellularity did not show significant changes227,228. The 
possible explanation for the discrepancy in the results might lie in differences in the 
experimental set up used. We conducted our experiments using embryonic thymus 
transplantation, while in above listed studies straight forward analyses of animals 
have been done. The possible influence of experimental manipulation on the overall 
thymic physiology in our set up will be addressed by performing conditional knock out 
studies with the recently described Foxn1-Cre mouse line235. 
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We reasoned that reduced cellularity of Atg5-/- grafts mirrors impaired positive 
selection of a diverse, polyclonal set of T cell specificities that critically depend on the 
MHC class II epitopes generated via the autophagic route. In agreement with our 
interpretation, efficiency of positive selection in TCR transgenic systems correlated 
with the size of the grafted thymi. Atg5-/- thymi had significantly lower cellularity in 
TCR transgenic mice that displayed impaired positive selection, TCR-HA and Sep 
TCR (Figure 3b), while there was no difference in the cellularity of Atg5-/- and WT 
lobes in the systems where positive selection worked as efficient as on WT 
epithelium, AND TCR, Dep TCR, DO11.10 TCR (Figure 3c, Supplementary Figure 
6a). Furthermore, neither of three MHC class I- restricted TCR transgenic animals 
tested, P14, OT-I and H-Y TCR transgenic, showed neither a difference in the 
efficacy of positive selection on WT versus Atg5-/- epithelium nor a difference in the 
cellularity of transplanted lobes (Figure 3d). These data are consistent with the 
hypothesis that autophagy specifically molds the MHC class II, but not the MHC class 
I repertoire. In line with our findings, it has been convincingly shown that targeting of 
intracellular proteins to autophagosomes enhanced specifically CD4, but not CD8 T 
cell responses in in vitro cultures201. Furthermore, efficient positive selection of MHC 
class I- restricted TCR transgenic T cells on autophagy deficient epithelium adds 
another proof that there is no global effect of autophagy deficiency on the positively 
selecting thymic environment.  
 
It is worth mentioning here that even though we have not observed any differences in 
neither bulk CD8SP T cell selection (Figure 3a) nor in the positive selection of 
particular MHC class I- restricted TCR specificities (Figure 3d) we deem it likely that 
autophagy might have an indirect role in generation of MHCI/p complexes. It is 
known that the availability of proteasomal substrates can critically influence whether 
a particular antigen is going to be presented on MHC class I88, 236. As already 
mentioned in the introduction to MHC class I antigen loading, ubiquitinylated proteins 
are substrates for proteasomal degradation. On the other hand, although autophagy 
is generally considered to be a bulk, non-selective catabolic pathway, the specific 
autophagic uptake of ubiquitinylated proteins and aggregates has been described167, 
168, 214. Thus, it seems reasonable to speculate that autophagy may compete with the 
proteasomal degradation system for available intracellular proteins. Consequently, 
the shuttling of peptides into the MHC class I loading pathway might be more efficient 
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in autophagy deficient thymic epithelium. The slightly increased MHC class I 
expression level on Atg5-/- cTEC is in agreement with the above mentioned 
hypothesis (Figure 2c-upper panel). In this scenario, the influence of autophagy on 
the peptide repertoire presented on MHC class I molecules might be opposite to its 
effect on the generation of the MHCII/p repertoire. Autophagy might broaden the 
repertoire of epitopes presented on MHC class II and at the same time limit the 
diversity of the peptides presented on MHC class I molecules. 
 
In light of experimental evidence from our and other laboratories discussed above 
one can conclude that a highly diverse MHCp repertoire is essential for the 
generation of millions of different T cell specificities232, 233. A T cell repertoire that is 
selected on cTEC displaying reduced diversity of MHCII/p complexes is altered 
(Graphic 6), which supports the proposed theory that during the process of positive 
selection highly specific interactions between TCR and MHCp complexes are taking 
place. However, it still remains to be resolved if a particular TCR can be selected on 
only one specific MHCp complex or the selection of one TCR specificity can be 
driven by several different ligands.  
 
3.4    Autophagy and MHC class II ligandome in cTEC 
 
Comparable expression levels of MHC class II between Atg5-/- and WT cTEC (Figure 
2c) argues that the observed  defect in the CD4SP T cell repertoire selection is 
caused by alterations in MHC class II ligandome on autophagy deficient epithelium. 
Unfortunately, it is not possible to conduct direct cTEC ligandome analysis due to 
technical limitations141,142, hence we were unable to directly perform characterization 
of a peptide repertoire displayed by Atg5-/- and WT cTEC. Nonetheless, we observed 
a quantitative difference in the expression of a particular MHC II/p complex, I-Eα(52-68) 
bound to I-Ab molecule in Atg5-/-  cTEC (Figure 3). To our knowledge, this is the first 
study showing changes in the MHCII/p repertoire in autophagy deficient APC in an in 
vivo system. The difference in the expression level of a particular MHCII/p complex 
on Atg5-/- cTEC strongly supports our hypothesis that autophagy specifically shapes 
repertoire of peptides presented by MHC class II molecules on thymic epithelial cells. 
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Our findings are in good agreement with previous in vivo and in vitro studies which 
together came to the conclusion that cTEC have a remarkably low capacity to 
present exogenous antigens to T cells, while being capable of presenting intracellular 
antigens49,135,137. Here we show data arguing for a scenario in which autophagy 
allows for shuttling of intracellular proteins to the MIIC compartment of cTEC.  
 
Recent experimental evidence implies that the activation of autophagy also affects 
the activity of lysosomal proteases involved in MHC class II antigen processing. Up-
regulation of autophagy in B cell lines led to a time-dependent down regulation of 
cathepsin activity resulting in the generation of longer antigenic peptides from the 
same source proteins142. Lysosomal proteolysis in professional APC is very carefully 
balanced, as efficient degradation would ultimately lead to the complete destruction 
of antigenic protein fragments. Accordingly, professional APC in peripheral lymphoid 
organs, such as DC and B cells, have attenuated lysosomal proteolysis in 
comparison to less efficient APC like macrophages. Therefore, highly active 
lysosomal proteases have a negative influence on the antigen presentation capacity 
of the cell237-239. The observed effect of autophagy on lysosomal proteolysis in the 
study by Dengjel et al. can contribute to a more efficient generation of antigenic 
peptides with the optimal properties for the biding to the MHC class II groove. It is 
tempting to speculate that concomitant with delivering of intracellular antigen to MIIC 
in TEC, autophagy also influences the other aspects of antigen processing such as 
lysosomal proteolysis. In that way, autophagy would on one hand contribute to the 
diversity of MHCII/p repertoire and on the other, it would make them more efficient in 
generating peptides that are suitable for MHC class II binding.  
 
3.5   Medullary thymic epithelial cells and endogenous antigen loading 
        pathways   
 
The existence of endogenous MHC class II antigen loading pathways in mTEC and 
its importance for tolerance induction have been implicated more than a decade ago 
in the studies with transgenic animals expressing a model antigen in the nucleus240, 
241. By targeting the expression of a model antigen to the nucleus of either mTEC or 
DC the authors have shown that tolerance to MHC class II epitopes can be achieved 
only if the antigen is expressed in mTEC. Furthermore, the study suggested that the 
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cross presentation of mTEC derived antigen by DC is not necessary for antigen 
presentation, at least in ex vivo and in vitro assays. Thus, endogenous loading of 
nuclear antigens on MHC class II has been proposed to be a peculiar feature of 
mTEC. Similar observations came from studies of transgenic animals expressing a 
model antigen in mitochondrial membrane, though in this model system the antigen 
was ubiquitously expressed in all thymic stromal cells68. Using elegant bone marrow 
chimeras the authors were able to document that TEC can directly process and 
efficiently present mitochondrial antigens to developing CD4 T cells which results in 
the clonal deletion of antigen specific cells. However, the nature of a respective 
endogenous MHC class II loading pathway remained a mystery.  
 
The high constitutive level of autophagy in cTEC and mTEChi described in our study 
implies autophagy as an endogenous loading pathway that allows for presentation of 
nuclear and mitochondrial antigens in the above described systems. Furthermore, 
undetectable autophagy in DC may explain the observation of Oukka et al. that DC 
are unable to process and present nuclear antigens on MHC class II. Curiously, there 
is now accumulating evidence in the literature supporting suggested explanation, i.e., 
autophagy has been implicated as a pathway involved in endogenous loading of 
nuclear antigens in an in vitro system204 and peptide elution analyses upon induction 
of autophagy revealed up-regulation of nuclear proteins derived epitopes on MHC 
class II142. It is an intriguing question how the nuclear antigens are actually targeted 
to autophagosomes. Non-selective degradation of nuclear proteins would be 
hazardous for cell survival, and so far chaperones involved in a specific targeting of 
nuclear proteins for autophagosomal degradation have not been identified.  It may be 
possible that MHC class II epitopes derived from nuclear antigens actually originate 
from DRiPs, as it has been proposed for MHC class I bound epitopes242, 243. DRiPs 
are ubiquitinylated polypeptides86, thus they can be specifically recognized by 
p62/SQSTM1 and subsequently targeted to autophagosomes via p62 interaction with 
LC3 protein167, 214. Similarly, selective autophagosomal degradation of mitochondria 
has been repeatedly documented in different systems169. Hence, the model systems 
described by Kosmatopoulus and Hedrick groups provide an excellent tool for testing 
the role of autophagy in endogenous antigen loading in mTEC and its part in 
tolerance induction.  
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Our analyses of autophagic activity using GFP-LC3 reporter animals would imply that 
autophagy operates as an endogenous loading pathway in a subpopulation of mTEC 
(mTEChi) that are fully equipped for efficient antigen presentation (Figure 1). These 
findings may shed light on the observed different antigen presentation characteristics 
of mTEC-like cell lines135-137 and in situ antigen presentation features of mTEC49,244.  
While mTEC-like cell lines have proven to be efficient in presenting exogenous 
antigens, in vivo studies claim that mTEC are inefficient in capturing and/or 
processing extracellular proteins. Thus, the expression of a transgenic human C 
reactive protein (hCRP) by only few mTEC has been shown to be sufficient for the 
efficient deletion of autoreactive T cells, and furthermore the dependence on DC 
mediated cross presentation of mTEC derived antigens for the tolerance induction 
has been elegantly excluded in the study. On the other hand, if a model antigen has 
been introduced in the system as a serum-borne protein, tolerance induction was 
completely dependent on hematopoietic APC. Thus, these data argue that mTEC 
have a rather low capacity to sample the serum-borne antigens in vivo, but are 
efficient in presenting endogenous antigens to developing T cells49. According to the 
“terminal differentiation model” the Aire+mTEChi subset of mTEC is the most mature 
one and expresses the highest number of tissue restricted antigens4. However, the 
rapid turnover of terminally differentiated mTEC in vivo on one hand52, 53 and the 
impaired survival of CD80hi mTEC in thymic re-aggregation cultures52 led to the 
suggestion that  promiscuous expression of a wide array of genes has an apoptotic 
effect  which in turn precludes making  stable mTEC-like cell lines representing the 
mTEChi population. Thus, mTEC-like cell lines might rather mirror the characteristics 
of immature mTEC. It feels justified to conclude that the respective antigen loading 
characteristic among mTEC subtypes might be different. As we observed high 
autophagic activity in mTEChi subsets, we would like to suggest here that it is this 
subpopulation that primarily concentrates its MHC class II ligandome on cytosolic 
proteins.  
 
3.6   Autophagy and tolerance induction 
 
Transplantation of autophagy deficient thymi to athymic, nude animals (nu/nuthymus 
Atg5-/- chimeras) resulted in development of CD4 T cells with an activated phenotype 
(CD62LloCD69hiCD44hi) and inspection of peripheral organs from these chimeras 
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revealed massive lymphocytic infiltration in colon, uterus, Harderian gland, liver and 
lung. Furthermore, animals developed wasting disease that typically set in around 4-
6 weeks after grafting of Atg5-/- lobes.  Accordingly, inspection of animals revealed 
total loss of fat pads in nu/nu thymus Atg5-/- chimeras (Figure 4). Taken together, animals 
displayed autoimmunity-like disease which implicated that the tolerogenic potential of 
autophagy deficient thymic epithelium was impaired. Importantly, adoptive transfer of 
CD90 MACS purified peripheral cells from nu/nuthymus Atg5-/- chimeras into nude 
recipients recapitulated essentially all aspects of autoimmunity observed in original 
chimeras (Supplementary Figure 10). To exclude a potential contribution of “carry-
over” Atg5-/- hematopoietic cells to the development of the autoimmune like disease 
in nu/nuthymus Atg5-/- chimeras, we created bone marrow chimeras where WT animals 
have been reconstituted with Atg5-/- fetal liver cells. Inspection of peripheral organs 
revealed no signs of lymphocytic infiltration (Supplementary Figure 9). Thus, Atg5-/- 
hematopoietic cells do not contribute to the development of autoimmunity in our 
model.  
 
Recent studies in humans have implicated a strong genetic linkage between the 
autophagy-related genes ATG16L1 and IRGM (Immunity-Related GTPase, family M) 
and the development of Crohn´s disease, a form of inflammatory bowel disease (IBD) 
with a high incidence in the European and North American population245-247. A study 
by Kuballa and colleagues suggested that impaired clearance of bacterial micro-flora 
in autophagy deficient intestinal epithelium might have a role in the 
immunopathogenesis of Crohn´s disease248. Concerning the well established role of 
autophagy in clearance of intracellular pathogens this explanation seems 
plausible170,171,195,249. Our study offers another, mutually non exclusive explanation for 
the role of autophagy in the development of IBD, namely the breakdown of central 
tolerance to intestinal antigens. However, it has recently been shown that mice 
hypomorphic for Atg16L1 protein expression do not develop autoimmune responses 
directed towards intestinal tissue, but rather display a specific impairment in the 
function of Paneth cells176. The discrepancy in observed phenotypes with different 
strains of autophagy null animals and experimental set ups might be explained by the 
fact that in Atg16L1 hypomorphic mice autophagy is still active at the basal level, as 
mice survive after birth and do not show a typical autophagy null phenotype184,189, 
190,188. This explanation is in agreement with previous observations which suggested 
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that only small amounts of Atg5 protein are required for autophagy193,250. Thus, the 
basal level of autophagy operating in mTEC of Atg16L1 hypomorphic mice might be 
sufficient for the induction of tolerance to tissue specific antigens. On the other hand, 
autophagy has been shown to be indispensable for proliferation and survival of 
mature T cells in the periphery. Additionally, autophagy deficient T cells display 
impaired TCR signaling in response to antigen stimulation199. Therefore, lack of 
intestinal inflammation in Atg16L1 hypomorphic mice might further be explained by 
the inability of auto-reactive T cells to respond to self antigens in the periphery. 
Nevertheless, as Crohn´s disease is a highly complex genetic disorder on one 
hand251 and autophagy has been shown to play an important role in both innate and 
adaptive immune responses on the other188,249,252, we might be just at the tip of an 
iceberg in elucidating its role in different aspects of IBD pathology. 
 
We would like to suggest that the underlying reason responsible for the breakdown of 
immunological tolerance presented in this study is the interference with endogenous 
antigen loading pathways in Atg5-/- mTEC (Graphic 7). MTEC play an indispensable 
role in T cell tolerance induction by promiscuously expressing tissue specific 
antigens4,54,59,253,254. Autophagy enables mTEC to present intracellular antigens to 
developing T cells, hence interference with autophagy in mTEC allows self-reactive T 
cells to bypass the mTEC-dependent central tolerance mechanisms and escape to 
the periphery. At this point it is an unresolved issue whether the ability of Atg5-/- 
mTEC to delete self-reactive thymocytes (negative selection) or to induce FoxP3 
Treg is affected. We observed equal percentages of CD25+FoxP3+ positive cells in 
Atg5-/- grafts on both Bl/6 and BALB/c backgrounds (Figure3 and Supplementary 
Figure3). However, it remains to be determined if the repertoire of Treg in nu/nuthymus 
Atg5-/- and nu/nuthymus WT chimeras is the same. 
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Graphic 7. The role of autophagy in central tolerance induction. Autophagy shuttles 
intracellular tissue specific antigens expressed in mTEC to the MIIC and by doing so it 
contributes to their tolerogenic capacity. Interference with autophagy abolishes endogenous 
antigen presentation in mTEC which results in the escape of self-reactive T cells to the 
periphery and development of autoimmune disease. 
 
Additional factors might contribute to the development of autoimmunity in the 
nu/nuthymus Atg5-/- chimeras. One of the candidates would be a homeostatic proliferation 
of T cells induced by lymphopenia in nude animals255,256. However, as our control 
nu/nuthymus WT chimeras did not show any signs of wasting and immune-mediated 
tissue destruction (Figure 4) nor were the CD90 T cells from nu/nuthymus WT chimeras 
able to cause autoimmunity in athymic recipients (Supplementary Figure 10), one 
can exclude lymphopenia as a sole reason for the autoimmunity in our experimental 
set up. The potentially reduced T cell output from Atg5-/- grafts coupled with 
homeostatic expansion of self-reactive T cells that escape the thymic censorship and 
populate the periphery in nu/nuthymus Atg5-/- chimeras has to be taken into account.  
However, we observed in our initial experiments with transplantation of two Atg5-/- 
autophagy
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grafts into nude animals (nu/nu2xthymus Atg5-/-) recapitulation of the disease phenotype, 
which developed with faster kinetics, i.e., earlier onset of disease (data not shown). 
Thus, these data would argue that impaired T cell output is not the underlying reason 
for a breakdown of central tolerance, but lymphopenia driven homeostatic expansion 
of self-reactive T cells can contribute to the aggressiveness of autoimmunity 
observed in our study.  
 
Reduced diversity of MHCII/p complexes on Atg5-/- cTEC and altered positive 
selection of CD4 T cell repertoire may also contribute to development of 
autoimmunity in nu/nuthymus Atg5-/- chimeras. Thymocytes that fail to be positively 
selected can undergo a second round of TCRα rearrangement, as positive selection 
signaling is necessary for down-regulation of Rag expression26, 257, 258. A successful 
secondary rearrangement increases the chance for a T cell to get positively selected 
and escape death by neglect. Importantly, if the secondary TCRα rearrangement 
takes place on the second Vα allele, and not on the already rearranged one, T cells 
will have two different antigen specificities, i.e., two TCRα chains pairing with the 
same TCRβ chain234,259-262. It has been suggested that T cells with dual specificities 
increase the risk of autoimmunity, as they can be selected through one TCR chain, 
but the second TCR might be self-reactive. Furthermore, the competitive pairing of 
two different TCRα chains with the same TCRβ chain results in reduced expression 
of TCR on the cell surface. The low expression of an self-reactive receptor may 
enable the T cell to bypass thymic censorship and escape to the periphery70,263,264. 
Thus, secondary rearrangements increase the success rate of positive selection, but 
it comes with the prize of an elevated risk for the development of autoimmune 
diseases. The incomplete repertoire of MHCII/p complexes on Atg5-/- cTEC results in 
limited positively selecting niches for some TCR specificities and thus may cause 
more frequent secondary Vα gene rearrangements then in WT animals. Indeed, we 
observed such a phenomenon in the selection of Sep TCR transgenic T cells. If 
educated on autophagy deficient epithelium, Sep TCR transgenic T cells show 
increased expression of endogenously rearranged TCRα chains (Vα2 and Vα8.3), 
implying the existence of dual-specificity T cells (Supplementary Figure 4). However, 
lacking anti-clonotypic or Vα4 antibody, we were not able to formally show that 
endogenously rearranged and transgenic Vα chains are co-expressed in the same 
group of T cells. Nevertheless, the observed higher frequency of secondary TCRα 
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rearrangements can theoretically lead to increased numbers of T cells expressing 
two different TCR specificities on the cell surface and in that way can synergize with 
a failure of mTEC-dependent tolerance induction to govern autoimmunity observed in 
nu/nuthymus Atg5-/- chimeras. Therefore, it will be of utmost importance to precisely 
assign a role of autophagy in cTEC versus mTEC for the development of a self-MHC 
restricted, functionally competent and self tolerant T-cell repertoire. However, at the 
moment we are unable to address this question due to the lack of good cTEC and 
mTEC specific Cre transgenic mouse lines that would allow us to conduct conditional 
knock out studies by taking advantage of Cre/LoxP technology. 
 
As a note of caution, however, it should be said that the autoimmune response 
observed in our experimental set up could be directed against Atg5 protein-derived 
epitopes. T cells specific for Atg5 epitopes can bypass the mechanisms of central 
tolerance induction as Atg5 protein is not expressed in TEC. We consider this 
possibility unlikely, as Atg5 protein is constitutively expressed in all peripheral 
organs. Hence, we would expect a larger panel of organs to be affected in nu/nu 
thymus Atg5-/- chimeras if the autoimmunity was caused by Atg5 specific T cells. 
However, to formally exclude this possibility one would have to create a transgenic 
animal expressing a mutated form of the Atg5 protein, whereby the full length protein 
would still be expressed, but its autophagy-related function would be compromised 
160. In that way, TEC would be able to present most of the Atg5 derived epitopes and 
escape of self-reactive, Atg5 specific T cells to the periphery would be precluded. 
Furthermore, one can alternatively address this question by analyzing the 
immunological phenotype of the other autophagy null animals, such as already 
described Atg7, Atg3 and Atg16L knock outs188,184,190  .   
 
An important issue arising from our observations concerns the potential mechanism 
that primes naive, self reactive T cells in the periphery of nu/nuthymus Atg5-/- animals. 
The main players in the initiation phases of adaptive immune responses are DC. How 
are then “vetoed” T cells, specific for TSA expressed and presented by mTEC that 
escape thymic censorship on Atg5-/- thymic epithelium, activated in the periphery? 
One can think of a scenario in which DC pick up TSA in peripheral organs from 
apoptotic cells and migrate to the draining lymph nodes where they can prime self-
reactive T cells. The classical endocytic route of MHC class II loading, i.e., the 
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engulfment of apoptotic bodies by DC in the periphery, would theoretically allow for 
the generation of the same peptide epitopes from TSA as autophagic delivery to 
MIIC, as both pathways converge to the same proteolytic machinery. Once activated 
in the lymph nodes, self-reactive T cells will home to the peripheral organs where 
they can recognize cognate antigens. But here the new question arises: how are the 
antigens presented to self-reactive T cells at the site of inflammation? High 
constitutive autophagic activity in the Harderian gland under normal physiological 
conditions on one hand, and severe immune-mediated histo-pathological destruction 
of the gland in the nu/nuthymus Atg5-/- animals on the other is an interesting observation 
offering possible answer (Supplementary Figure 11). In the affected organs, 
inflammatory cytokines, such as IFNγ, might lead to the up-regulation of (i) MHC 
class II molecules and (ii) autophagy on fibroblasts, epithelial and endothelial cells195, 
265. By up-regulating autophagy and MHC class II, stromal cells in targeted organs 
might allow for delivery of intracellular protein to MIIC and subsequent antigen 
presentation, as it has been convincingly shown for human epithelial cell lines201 . 
Curiously, in studies of psoriasis in humans it has been documented that CD4 T cells 
with cytolytic activity frequently surround MHC class II positive epithelial cells266. 
Thus, it seems reasonable to speculate that similar modes of antigen presentation in 
peripheral organs occur in our experimental set up once the self-reactive T cells find 
themselves in the target organs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
             DISCUSSION 
58 
 
3.7   Proposed model and concluding remarks 
 
“The division of labor” hypothesis has been proposed nearly a decade ago, which 
postulates that mTEC and DC sample and present a non overlapping pool of self 
antigens to developing T cells. However, the nature of the pathway/s that enables 
TEC to concentrate their MHC class II ligandome on the intracellular milieu (Graphic 
8) remained undefined at the time. Here we presented evidence that autophagy can 
operate as an endogenous MHC class II loading pathway in TEC. In that way it 
contributes to the diversity of MHCII/p complexes in cTEC that are displayed to the 
developing thymocytes during positive selection and at the same time broadens the 
repertoire of MHCII/p complexes in mTEC, which are displayed to thymocytes during 
the process of tolerance induction in the medulla. 
 
 
 
Graphic 8. Proposed model of different MHC class II antigen loading routes in thymic 
stromal cell subtypes. Autophagy delivers intracellular proteins to MIIC of cortical and 
medullary thymic epithelial cells (cTEC and mTEC) and in that way broadens the repertoire 
of MHCII/p complexes that is presented to developing CD4 T cells during the processes of 
positive selection and tolerance induction. Dendritic cells (DC) efficiently sample extracellular 
proteins and generate MHC class II epitopes via the classical antigen loading pathway. 
 
cTECs - positive selection
mTECs - tolerance induction
endogenous loading pathways- autophagy
DCs - tolerance induction
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             DISCUSSION 
59 
 
We focused our research on the role of macroautophagy, as this pathway has been 
shown to display an atypically high activity in TEC and the genetic tools for studying 
and manipulating macroautophagy were available. However, other alternative 
pathways of MHC class II antigen loading can as well operate in the thymic 
epithelium and/or DC and in that way contribute to T cell development. Chaperone 
mediated autophagy is an interesting candidate, as it was convincingly shown in in 
vitro assays that it can contribute to MHC class II loading152. However genetic 
manipulation of essential players in CMA, Hsc70 and LAMP2a, affects other basic 
cellular processes. LAMP2 deficient animals display a general problem in the 
process of endosomal/lysosomal fusion and accumulation of early autophagosomes 
in a large panel of tissues which makes analyses of CMA contribution to MHC class II 
loading very difficult to interpret267,268. In the same line, Hsc70 is involved in many 
basic cellular processes. As a molecular chaperone Hsc70 binds numerous proteins 
thereby mediating both folding and degradation269. One possible approach to study 
CMA in antigen loading would be the generation of miRNA transgenic animals 
specific for LAMP2a isoform of the LAMP2 protein, whereby the CMA knock down 
phenotype could be analyzed. The list of other putative endogenous loading 
pathways includes microautophagy, which is a genetically poorly characterized 
process, and TAP dependent MHC class II loading. The contribution of these 
endogenous antigen loading pathways for the generation of a highly diverse MHCII/p 
repertoire on thymic APC remains to be elucidated in the years that follow. 
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4. Materials and Methods 
Animals. Atg5–/– and GFP-LC3 mice have been described previously 161, 189. BALB/c 
nu/nu and HY TCR transgenic animals were purchased from Taconic Farms. AND and 
OT-I TCR transgenic and B10.A animals were obtained from Jackson Laboratories. 
AND, P14, OT-I, HY, TCR-HA, DO11.10, Sep and Dep TCR transgenic animals were 
described elsewhere223, 270, 271, 29, 244, 272, 273. P14 TCR transgenic animals were a kind 
gift from Prof. Penninger. All mice were bred and maintained in individually ventilated 
cages in the animal facility of the Research Institute of Molecular Pathology (Vienna, 
Austria) under specific pathogen-free conditions. All animal studies were approved by 
local authorities (MA58) and were done according to Austrian regulations. 
Genotyping 
DNA samples for the genotyping were prepared by 5h digestion of tail pieces at 55°C 
in the tail-buffer followed by thermal inactivation of proteinase K by incubation of the 
reaction mixture for 5 min at 95°C. Atg5-/- animals were genotyped using primers 
LK39 5´-GAATATGAAGGCACACCCCTGAAATG-3´ and LK40 5´- 
ACAACGTCGAGCACAGCTGCGCAAGG-3´ for the wild type allele, and LK40 and 
LK41 5´- GTACTGCATAATGGTTTAACTCTTGC-3´ for the knock-out allele. The 
Atg5+/+ allele gives a PCR product of 351bp, while the Atg5-/- allele gives a PCR 
product of 574bp. Amplification conditions were as for the Atg5 program as detailed 
in the supplementary methods. GFP-LC3 transgenic animals were genotyped using 
primers LK35 5´-TCCTGCTGGAGTTCGTGACCG-3´ and LK36 5´- 
TTGCGAATTCTCAGCCGTCTTCATCTCTCTCGC-3´ for the transgenic allele, and 
LK37 5´-TGAGCGAGCTCATCAAGATAATCAGGT-3´ and LK38 5´- 
GTTAGCATTGAGCTGCAAGCGCCGTCT-3´for the wild type allele. The GFP-LC3+/+ 
allele gives a PCR product of ~400bp; while the wild type allele gives a PCR product 
of ~500bp. Amplification conditions were as for the TD 54x30 program as detailed in 
the supplementary methods. AND TCR transgenic animals were genotyped using 
primers AND5 5´- GACTTGGAGATTGCCAACCCATATCTAAGT-3´and AND3 5´- 
TGAGCCGAAGGTGTAGTCGGAGTTTGCATT-3´ using amplification conditions as 
for the TD54x30 program. The transgenic allele gives a PCR product of ~410bp. Dep 
TCR transgenic animals were genotyped using primers LK28 5´- 
CGAGAGGAAGCATGTCTAAC-3´ and LK29 5´- ACCGCGGTCATCCAACACAG-3´. 
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Amplification conditions were as for the TD54x30 program, and the transgenic allele 
gives a PCR product of ~650bp. Sep TCR transgenic animals were genotyped using 
primers LK44 5´-AGTCGCGAGATGGGCTCC-3´ and LK45 5´- 
CGCGGTCATCCAACACAG-3´ using amplification conditions as for the TD54x30 
program. The transgenic allele gives a PCR amplicon of ~550bp. TCR-HA TCR 
transgenic animals were genotyped using primers TCR-HA5 5´- ACA AGG TGG 
CAG TAA CAG GA-3´and TCR-HA3 5´- ACA GTC AGT CTG GTT CCT GA-3´using 
amplification conditions as for the TD54x30 program. The transgenic allele gives a 
PCR product of ~800bp. DO11.10 TCR transgenic animals were genotyped using 
primers DO11.10-5 5´- CAGGAGGGATCCAGTGCCAGC-3´and DO11.10-3 5´- 
TGGCTCTACAGTGAGTTTGGT-3´. The transgenic allele gives a PCR product of 
~290bp using TD54x30 PCR program. OT-I TCR transgenic animals were genotype 
using primers JN40 5´- AAGGTGGAGAGAGACAAAGGATTC-3´and JN41 5´- 
TTGAGAGCTGTCTCC-3´. The amplifications conditions were as for the OT-I 
program as detailed in the supplementary methods. The transgenic allele gives a 
PCR product of ~300bp. P14-TCR transgenic animals were genotyped using primers 
JN46 5´- CGAGGATCCTTTAACTGGTACACAGCACG-3´and JN47 5´- 
CTGACCTGCAGTTATGAGGACAGCAC-3´. The amplification conditions were as for 
the P14 PCR program as detailed in the supplementary methods. The transgenic 
allele gives a PCR amplicon of ~200bp. HY-TCR transgenic animals were genotyped 
using primers HY-1 5´- GCTTTGAGGCGGAGTTTAGG-3´and HY-2 5´- 
GCTCACTGTCAGCTTTGTCC-3´. The amplification conditions were as for the HY 
program as detailed in the supplementary methods. The transgenic allele give a PCR 
product of ~300bp. Rag2-/- animals were genotyped using primers RAG2-5´ 5´- 
GCAACATGTTATCCAGTAGCCGGT-3´ and RAG2-3´ 5´-
TTGGGAGGACACTCACTTGCCAGT- 3´ for the wild type allele, and RAG2-5 and 
RAG2-int 5´ - GTATGCAGCCGCCGCATTGCATCA-3´ for the knock out allele. 
Amplification conditions were as for the TD54x30 program. The wild type allele gives 
a PCR product of ~605bp, while the knock out allele gives a PCR product of 
~1000bp. Male embryos were genotyped using primers MA329 5´- 
TTGTCTAGAGAGCATGGAGGGCCATGTCAA-3´ and MA330 5´- 
CCACTCCTCTGTGACACTTTAGCCCTCCGA-3´ that are specifically amplifying Y-
chromosome linked SRY antigen. The amplification conditions were as for the 
TD54x30 and male allele gives a PCR product of ~400bp. 
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Antibodies and flow cytometry. Biotin-conjugated monoclonal antibody (mAb) Y-
Ae was a kind gift of Prof. B. Kyewski. Biotin-conjugated mAbs to CD62L (MEL14), 
CD80 (16-10A1), CD11c (HL3), Vβ3 (KJ25) and Vβ14 (14-2), fluorescein 
isothiocyanate (FITC)–conjugated mAbs to CD62L (MEL14), CD90.1 (HIS51), H-2Kb 
(AF6-88.5), Vα8.3 (KT50),Vβ3(KJ25),Vβ4 (KT4), Vβ5.1,5.2 (MR9-4), Vβ6 (RR4-7), 
Vβ8.1/2 (MR5-2), Vβ8.3 (1B3.3), Vβ13 (MR12-3), phycoerythrin (PE)-conjugated 
mAbs to CD69 (H1.2F3), Ly51 (BP-1), Vα2 (B20.1),Vα11.1,11.2 (RR8-1), Vβ2 
(B20.6),Vβ7 (TR310),Vβ8.3 (1B3.3),Vβ10 (B21.5), CyChrome-conjugated mAbs to 
CD8 (53-6.7), CD45 (30-F11), phycoerythrin-Cy7 conjugated mAb to CD25 (PC61), 
allophycocyanin (APC)-conjugated mAbs to CD4 (RM4-5) and CD8 (52-6.7), 
allophycocyanin-indotricarbocyanin-conjugated mAb to CD4 (GK1.5), PE-Cy7-
conjugated streptavidin and FITC–conjugated straptavidin were purchased from 
Becton Dickinson. PE-conjugated mAb to TCR-HYα (T3.70) was purchased from 
eBiosciences. Ulex europaeus agglutinin (UEA-1) was purchased from Sigma Aldrich 
and conjugated to Alexa 647 in our lab. mAbs specific for TCR-HA (6.5), DO11.10 
(KJ1-26), EpCAM (G8.8), Vβ8 (F23.1), pan-MHC class II (P7.7) and CD4 (GK1.5) 
were purified from hybridoma supernatants and conjugated to biotin, Alexa Fluor 488 
or Alexa Fluor 647 in our lab. Surface staining was done according to standard 
procedures at a density of 1x106 to 3x106 cells per 50 µl. FoxP3 intracellular staining 
was done according to the manufacturer’s recommendations with phycoerythrin- or 
allophycocyanin-conjugated mAb to mouse FoxP3 (FJK-16s, eBiosciences, San 
Diego, CA). A FACSCanto (Becton Dickinson) with FACSDiva software (Becton 
Dickinson) was used for data acquisition and the Flow Jo software was used for data 
analysis. 
Intracellular staining. As previously mentioned, Foxp3 intracellular staining was 
performed according to the manufacturer’s recommendations using PE- or APC- 
conjugated anti-mouse Foxp3 mAb (eBiosciences). In brief, 5 × 106 cells were 
centrifuged at 2000 r.p.m. for 5 minutes at 4 °C in FACS tubes and stained in 100 µl 
FACS buffer (1x PBS, 2% FCS, 1 mM EDTA) containing appropriate  cell surface 
markers, i.e., anti-CD4,CD8 and CD25 mAbs. Cells were washed with 1 ml FACS 
buffer, centrifuged as before and resuspended in 1 ml 1X Fixation/Perm buffer from 
Ebioscience Foxp3 staining kit.  Cells were incubated either overnight or for 3h at 4 ° 
C in the dark.  Cells were subsequently washed two times with 1 ml Permeabilization 
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Buffer from eBioscience Foxp3 staining kit and resuspended in 50 µl 2 % rat serum 
diluted in Permeabilization buffer.  Cells were incubated in the dark on ice for 15 
minutes. Appropriate volume of PE conjugated anti-mouse Foxp3 mAb from 
eBiosciences was added to the cell suspension and the cells were incubated on 4°C 
in the dark for 45 minutes.  Cells were washed in 1 ml Permeabilisation buffer and 
resuspended in 200 µl FACS buffer before analysis. 
Immunofluorescence. Frozen sections (5µm) were fixed in cold acetone, washed 
and blocked for 30 min with 10% (vol/vol) FCS in PBS. Sections were permeabilized 
in 0.1% (vol/vol) Tween in PBS for 10 min, and stained overnight at 4°C with 
biotinylated anti keratin 8 antibody (TROMA-1, Developmental Studies Hybridoma 
Bank). Sections were incubated with secondary antibody for 90 min at room 
temperature, and after washing 3 times for 15 min each in 0.1% (vol/vol) Tween in 
PBS were blocked with anti-rat serum (Jackson Immuno Research Laboratories, Inc.) 
for 30 min at room temperature. After washing, sections were incubated with anti-
keratin 5 antibody (Covance) for 2 h at room temperature. Secondary reagents were 
straptavidin-Cy3 (Jackson Immuno Research Laboratories,Inc.) and Alexa Fluor 488-
conjugated anti-rabbit antibody (Molecular Probes). Nuclei were counterstained with 
ProLong Gold antifade reagent with 4, 6-diamidino-2-phenylindole (DAPI) (Molecular 
Probes). Samples were analyzed with an inverted confocal LSM 510 laser scanning 
microscope (Carl Zeiss AG, Germany). 
GFP-LC3 analyses. GFP-LC3 mice and WT controls were maintained on normal diet 
or kept without food for 48 hours before analyses with free access to drinking water. 
Prior to analyses, mice were anaesthetized and perfused through the left heart 
ventricle with 4% paraformaldehyde (PFA) in PBS. Organs were harvested and 
further fixed with the same fixative for 4h, followed by treatment with 15% sucrose in 
PBS for 4h at room temperature and then with 30% sucrose solution overnight at 
4°C. Tissue samples were embedded in O.C.T. (Sakura Finetek Europe B.V.) and 
stored at -70°C. The samples were sectioned (5µm), and stained with Alexa Fluor 
488 conjugated anti-GFP antibody (Molecular Probes) overnight at 4°C. Samples 
were mounted using ProLong Gold  antifade reagent with DAPI. 
Quantification of autophagic activity in thymic stromal cells. Thymi from two 
week old GFP-LC3 mice were cut into small pieces and digested at 37 °C in IMDM 
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containing 0.2 mg/ml Collagenase (Roche), 0.2 mg/ml Dispase I (Roche), 2% FCS, 
25mM Hepes (pH 7.2) and 25 μg/ml DNase I, followed by incubation in 5 mM EDTA 
for 5 min. Cells were washed and resuspended in PercollTM (GE Healthcare) (ρ 
1.115), followed by a layer of PercollTM (ρ 1.050) and PBS as upper phase. Gradients 
were spun for 30 min at 1350g in the cold and low density cells were harvested from 
the upper interface, washed and stained for FACS sorting. Stromal cells were sorted 
according to CD45, Ly51, EpCAM, CD80 and CD11c expression (cTEC = CD45-
Ly51+EpCAM+; mTEClo CD45-Ly51-EpCAM+CD80lo, mTEChi CD45-Ly51-
EpCAM+CD80hi; DC = CD45+CD11c+) and fixed onto poly-L-lysine–coated slides 
(Sigma Aldrich) with ice cold acetone. Cells were permeabilized in 0.1% (vol/vol) 
Tween in PBS for 10 min, and blocked with 10% (vol/vol) FCS in PBS for 30 min at 
room temperature. Cells were incubated overnight at 4°C with Alexa Fluor 488 
conjugated anti-GFP antibody and mounted with ProLong Gold antifade reagent with 
DAPI. A total of 1000 dendritic cells, 1845 cTEC, 1232 mTEChi and 245 mTEClo have 
been analyzed for determination of the percentage of autophagy positive cells. Cells 
with more than 5 autophagosomes (= GFP positive punctae between 0.5 and 1.5 µm 
in diameter) were scored positive. For quantification of the number of 
autophagosomes per cell, a total of 81 autophagy positive cTEC and 51 autophagy 
positive mTEChi have been recorded and analyzed. Cells were analyzed with an 
inverted confocal LSM510 Zeiss microscope by taking Z stacks of 0.5 µm thickness 
and subsequently the number of autophagosomes in the whole cell volume was 
determined. 
Purification and adoptive transfer of T cells. Pooled cell suspensions of spleen 
and lymph nodes (mesenteric, inguinal, axillary, brachial, superficial cervical, deep 
cervical and lumbar) from nu/nuAtg5-/- and nu/nuwt chimeras were subjected to 
erythrocyte lysis. Cells were then incubated with Fc-receptor-blocking antibody 
(2.4G2) and were stained with biotin-anti-CD90. After incubation with streptavidin 
microbeads (Miltenyi Biotec), CD90+ cells were positively selected on midi-MACS 
columns. 1x107 CD90+ cells were injected in a volume of 200µl in PBS into the lateral 
tail veins of BALB/cnu/nu animals. Animals were analyzed 6-12 weeks after transfer. 
Thymus transplantation. Embryonic thymi (E16.5-E15.5) (with or without dGuo 
treatment) were transplanted under the kidney capsule of female animals. Recipient 
animals were anesthetized with ketamine/xylazine prior to transplantation. Atg5–/– 
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embryos and Atg5+/+ (WT) controls within individual experiments were obtained from 
the same Atg5+/– pregnant female after mating to an Atg5+/– male. For the analyses of 
efficacy of positive selection in HY-TCR transgenic animals, the gender of embryos 
have been determined by genotyping as detailed in the genotyping section of 
materials and methods. In this experimental set up only female embryos were used 
as thymic donors. 
Deoxyguanosine treatment. E15.5-E16.5 thymic lobes were placed on 0.45µm 
membrane filters (Milipore) supported by Gelfoam (Pharmacia&Upjohn) and were 
incubated for 5 days with 10% FCS (vol/vol) IMDM supplemented with 1.35 mM 2-
deoxyguanosine, glutamine, β-mercaptoetanol, penicillin and streptavidin n 37°C 
incubator before transplantation. 
Bone marrow chimeras. For mixed bone marrow chimeras CD90 depleted TCR-HA 
rag2–/– CD45.1+/+ and DO11.10 rag2–/– CD45.1+/– bone marrow was mixed at a ratio 
of 1:1 and a total of 1x107 cells were injected into the lateral tail vein of irradiated 
BALB/c  recipients (2 × 450 rad). Animals were transplanted with Atg5–/– or Atg5+/+ 
(WT) lobes 4 weeks after bone marrow reconstitution. Grafts were analyzed 6 weeks 
after transplantation.  
Fetal liver chimeras.  Fetal livers were harvested from E15.5-E16.5 embryos. Single 
cell suspensions were filtered through nylon mash filters (BD Bioscience) and directly 
used as donor cells for reconstitution experiments. A total of 5.5 × 106 fetal liver cells 
were injected into the lateral tail veins of irradiated (2 × 550 rad) CD45.1 C57BL/6 
recipients. Chimeras were analyzed 12 weeks after reconstitution. 
Semiquantitative RT-PCR. mTEC were isolated from 4-5  transplanted thymi as 
described above and total RNA was isolated using the High Pure RNA isolation kit 
(Roche). RNA was reverse transcribed using the iScript RT kit (Biorad). PCR 
reactions were carried out in a final volume of 25μl using the Advantage 2 
Polymerase mix (Clontech) and Advantage 2 PCR buffer SA (Clontech) according to 
the manufacturers recommendations. dNTPs (Fermentas) were used at a final 
concentration of 200μM and primers were used each at 400nM final concentration. 
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Primer list: 
Primer            Sequence                                                       Amplicon size 
Aire forward:    5’- GAGTCACAGCACCTTCCTCTT - 3’         (438bp) 
Aire reverse:    5’- GGGACAGCCGTCACAACA - 3’               (438bp) 
Spt1 forward:   5’- TGAAACTCAGGCAGATAG - 3’                (383bp) 
Spt1 reverse:   5’- GAGGGAGAATAGTCAGGAT - 3’             (383bp) 
Tff3 forward:    5’- CTGGCTAATGCTGTTGGTG- 3’               (377bp) 
Tff3 reverse:    5’- TGTTGGCTGTGAGGTCTTT - 3’               (377bp) 
Csn2 forward:  5’- TCATCCTCGCCTGCCTTGT - 3’               (401bp) 
Csn2 reverse:  5’- GCGGAGCACAGTTTCAGAGTT - 3’         (401bp) 
Actb forward:   5’- GGTGGGAATGGGTCAGA - 3’                  (380bp)  
Actb reverse:   5’- GAGCATAGCCCTCGTAGAT- 3’               (380bp) 
 
All amplicons span at least one intron. Cycling conditions were as follows: 94°C for 
3min; 31 × (Actb), 34 × (Aire), 36 × (Csn2/Tff3), 38 × (Spt1) [94°C for 20s, 56°C for 
30s, 72°C for 30s]; 72°C for 5min. Samples were run on a 1.5 % (w/v) Agarose / EtBr 
gel in TAE buffer. 
 
Histopathology. Organs were harvested from donor animals and immersion-fixed 
with either 4% paraformaldehyde (PFA) overnight at 4°C or in an IHC Zink Fixative 
(Becton Dickinson) for 48 hours at room temperature. Samples were embedded in 
paraffin blocks. Sections (3-5 µm thick) were stained with hematoxylin and eosin (H & 
E) and automatically scanned using the Zeiss MIRAX SCAN system. Subsequently, 
sections were analyzed “blind” using the Zeiss MIRAX VIEWER software (Carl Zeiss 
AG, Germany). 
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Supplementary Methods- Genotyping Primers 
Primers        Sequence                                                                   Description 
DO11.10 5´ CAGGAGGGATCCAGTGCCAGC sense DO11.10 TCR  
DO11.10 3´ TGGCTCTACAGTGAGTTTGGT antisense DO11.10 TCR  
TCR-HA 5´ ACA AGG TGG CAG TAA CAG GA sense TCR-HA  
TCR-HA 3´ ACA GTC AGT CTG GTT CCT GA antisense  TCR-HA  
LK28 CGAGAGGAAGCATGTCTAAC sense Dep TCR  (beta chain) 
LK29 ACCGCGGTCATCCAACACAG antisense Dep TCR  (beta chain) 
LK44 AGTCGCGAGATGGGCTCC Sep TCR beta chain sense 
LK45 CGCGGTCATCCAACACAG Sep TCR beta chain antisense 
AND 3´ TGAGCCGAAGGTGTAGTCGGAGTTTGCATT AND TCR antisense  
AND 5´ GACTTGGAGATTGCCAACCCATATCTAAGT AND TCR sense  
HY 1 GCTTTGAGGCGGAGTTTAGG HY TCR  forward 
HY 2 GCTCACTGTCAGCTTTGTCC HY TCR  reverse 
JN40 AAGGTGGAGAGAGACAAAGGATTC OT-I TCR  forward 
JN41 TTGAGAGCTGTCTCC OT-I TCR reverse 
JN46 CGAGGATCCTTTAACTGGTACACAGCACG P14 TCR forward 
JN47 CTGACCTGCAGTTATGAGGACAGCAC P14 TCR reverse 
LK39 GAATATGAAGGCACACCCCTGAAATG ATG5 exon3-1  
LK40 ACAACGTCGAGCACAGCTGCGCAAGG ATG5 check2  
LK41 GTACTGCATAATGGTTTAACTCTTGC ATG5 short2 
LK35 TCCTGCTGGAGTTCGTGACCG GFP1 for GFP-LC3  
LK36 TTGCGAATTCTCAGCCGTCTTCATCTCTCTCGC LC3 rc3 
LK37 TGAGCGAGCTCATCAAGATAATCAGGT mLC3 ex3GT 
LK38 GTTAGCATTGAGCTGCAAGCGCCGTCT mLC3 ex4AG  
RAG2 3' TTGGGAGGACACTCACTTGCCAGT RAG2 3' primer 
RAG2 5' GCAACATGTTATCCAGTAGCCGGT RAG2 5' primer 
RAG2 int GTATGCAGCCGCCGCATTGCATCA RAG2 internal primer (ko) 
 MA329             TTGTCTAGAGAGCATGGAGGGCCATGTCAA             SRY forward –male specific 
 MA330             CCACTCCTCTGTGACACTTTAGCCCTCCGA             SRY reverse-male specific 
 
 
                                                                                                                   MATERIALS AND METHODS 
 
68 
 
Supplementary Methods- PCR protocols 
TD 54 × 30     
                                                                
94 °C 3:00 min 1× cycle 
   
94 °C 0:45 min  
60 °C 0:45 min 2× cycles 
72 °C 1:00 min 
 
94 °C 0:45 min 
58 °C 0:45 min 2× cycles 
72 °C 1:00 min   
  
94 °C 0:45 min 
56 °C 0:45 min 2× cycles 
72 °C 1:00 min 
  
94 °C 0:45 min 
54 °C 0:45 min 30× cycles 
72 °C 1:00 min  
 
72 °C 5:00 min 1× cycle 
 
 
HY-TCR  
95°C 15 min           1x cycle 
95°C   45 sec 
60°C   1 min              30x cycles 
72°C   1 min   
72°C 5 min              1x cycle  
 
OT-I TCR 
 
94° C   3 min 
 
94 °C   30 sec 
52° C   30sec               38x cycles 
72 °C   30sec 
 
72° C    2 min 
15° C   for ever 
 
Atg5 program 
94°C   3 min 
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94°C   30 sec          
60°C   30 sec        36x cycles 
72°C   30 sec 
 
72°     10 min 
 
 
Tail digestion program 
 
55°C   5 hours 
95°C   5 min 
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